aifi_cell_type,timepoint,fg,bg,n_sample,gene,coef_C,coef_D,logFC,nomP,adjP,direction_sign,direction,alt_name,branch,y_offset,group,order,gene_ypos,gene_label,treat_label,cell_type_label,cell_type_color,cell_type_xpos,cell_type_ypos
t_cd4_cm,24,bortezomib,dmso,648,BCL10,0.062854923507439,0.0997817897424178,0.0186618833838443,0.313667208982933,0.606855744526941,1,up,,PKCθ–IKK–NF-κβ pathway,4,CBM complex,36,40,BCL10,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,24,bortezomib,dmso,648,CARD11,0.00973736936386028,-0.0129473030307995,-3.13648493955876e-05,0.956837802940291,0.983918694162955,-1,dn,CARMA1,PKCθ–IKK–NF-κβ pathway,4,CBM complex,34,38,CARD11 | CARMA1,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,24,bortezomib,dmso,648,CD247,-0.00965959590621804,-0.00850833800548937,-0.0104805857125043,0.961046978913295,0.98616266010048,-1,dn,CD3ζ,Initial TCR Response,5,TCR complex,56,61,CD247 | CD3ζ,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,24,bortezomib,dmso,648,CD3D,-0.0221940170408182,-0.0126579715595997,-0.0170324951148653,0.734695138352088,0.881053297354601,-1,dn,CD3δ,Initial TCR Response,5,TCR complex,60,65,CD3D | CD3δ,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,24,bortezomib,dmso,648,CD3E,-0.0158601467051765,-0.390771581893316,-0.122526328877917,0.00459449776694178,0.0489106467827092,-1,dn,CD3ε,Initial TCR Response,5,TCR complex,61,66,CD3E | CD3ε,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,24,bortezomib,dmso,648,CD3G,-0.0573684476984417,-0.52031353828583,-0.197496097045056,7.47336842924261e-06,0.00023686116208204,-1,dn,CD3γ,Initial TCR Response,5,TCR complex,57,62,CD3G | CD3γ,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,24,bortezomib,dmso,648,CD4,0.0432130603241706,-0.220464336891612,-0.0521105336779418,0.0743294895983443,0.296244185453859,-1,dn,,Initial TCR Response,5,TCR Coreceptor,55,60,CD4,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,24,bortezomib,dmso,648,CHUK,0.0384669637781663,0.144962655650442,0.02566374356304,0.484124980117885,0.73326633044246,1,up,IKKɑ,PKCθ–IKK–NF-κβ pathway,4,IKb Kinase complex,30,34,CHUK | IKKɑ,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,24,bortezomib,dmso,648,CSK,0.0219949884516449,-0.247214512450761,-0.0351292820785175,0.252538126942349,0.543190390035025,-1,dn,,Initial TCR Response,5,TCR Negative Regulator,48,53,CSK,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,24,bortezomib,dmso,648,DGKA,-0.0122373401463747,-0.0843156707523869,-0.0354810494670127,0.685510198388872,0.855238882120593,-1,dn,DGKɑ,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,19,22,DGKA | DGKɑ,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,24,bortezomib,dmso,648,FOS,-0.0371463019116365,-0.718511692399564,-0.0565227810661608,0.00561977887559815,0.0565573480679273,-1,dn,c-Fos,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,20,23,FOS | c-Fos,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,24,bortezomib,dmso,648,FYN,-0.0320423872222204,-0.210856407545702,-0.0861414699796041,0.240444012465302,0.533132192183357,-1,dn,,Initial TCR Response,5,ITAM-targeting Kinase,51,56,FYN,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,24,bortezomib,dmso,648,GRAP2,-0.0194356805583328,-0.264200236541137,-0.124015379518146,0.0652657358087469,0.272550226135445,-1,dn,GADS,Initial TCR Response,5,Phospholipase C complex,42,47,GRAP2 | GADS,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,24,bortezomib,dmso,648,IKBKB,-0.0505518475175141,-0.0347304454323445,-0.0218388586831083,0.310384634175973,0.603615296812421,-1,dn,IKKβ,PKCθ–IKK–NF-κβ pathway,4,IKb Kinase complex,31,35,IKBKB | IKKβ,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,24,bortezomib,dmso,648,IKBKG,-0.000617328878932329,-0.204266908815688,-0.0118434164431577,0.73166432012457,0.879032070033677,-1,dn,IKKγ,PKCθ–IKK–NF-κβ pathway,4,IKb Kinase complex,29,33,IKBKG | IKKγ,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,24,bortezomib,dmso,648,ITK,-0.0860707852174545,-0.612740007734654,-0.284509220192853,1.08289937298651e-07,4.91879533376868e-06,-1,dn,,Initial TCR Response,5,Phospholipase C complex,41,46,ITK,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,24,bortezomib,dmso,648,JUN,-0.0236715847408917,-0.331388767767323,-0.0859870084335547,0.0471391689385634,0.224188186430099,-1,dn,c-Jun,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,21,24,JUN | c-Jun,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,24,bortezomib,dmso,648,LAT,-0.00631026631915047,-0.487177363032281,-0.116718126828616,0.00153691384447434,0.0211238611569014,-1,dn,,Initial TCR Response,5,Phospholipase C complex,43,48,LAT,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,24,bortezomib,dmso,648,LCK,0.0242514129193537,-0.297190418474585,-0.0940154365726749,0.0315174330446331,0.176124392290206,-1,dn,,Initial TCR Response,5,ITAM-targeting Kinase,52,57,LCK,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,24,bortezomib,dmso,648,LCP2,-0.138945487721931,-0.544097823996402,-0.29885362022216,5.88783114361378e-10,3.81765173540881e-08,-1,dn,SLP-76,Initial TCR Response,5,Phospholipase C complex,44,49,LCP2 | SLP-76,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,24,bortezomib,dmso,648,MALT1,-0.0801159665240809,-0.254407345345622,-0.139535530571573,0.00371566360411898,0.0418024458985253,-1,dn,,PKCθ–IKK–NF-κβ pathway,4,CBM complex,33,37,MALT1,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,24,bortezomib,dmso,648,MAP2K1,0.030717725237281,0.29510573319703,0.114083343232616,0.0319085210710177,0.177608766695429,1,up,MEK1,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,15,17,MAP2K1 | MEK1,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,24,bortezomib,dmso,648,MAP2K2,0.0424640457479142,0.155398462012541,0.0246036736689836,0.350956489884702,0.637760643654094,1,up,MEK2,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,14,16,MAP2K2 | MEK2,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,24,bortezomib,dmso,648,MAP2K7,-0.0278935043865447,0.422998071299021,0.0408354496366334,0.0761893332163486,0.301562067259862,1,up,MKK7,p38 and JNK pathways,1,JNK activation complex,9,10,MAP2K7 | MKK7,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,24,bortezomib,dmso,648,MAP3K7,-0.0278170674802863,0.0690472501076524,0.0143268851373006,0.597596410904448,0.803569832501803,1,up,TAK1,p38 and JNK pathways,1,JNK activation complex,10,11,MAP3K7 | TAK1,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,24,bortezomib,dmso,648,MAPK1,0.0518527846756034,-0.0147439143920035,0.0144274209281042,0.225374527835334,0.515992247825694,1,up,ERK2,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,13,15,MAPK1 | ERK2,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,24,bortezomib,dmso,648,MAPK14,0.0362141698492679,-0.136400766441229,-0.0364214416115612,0.24899609657683,0.540360971978436,-1,dn,p38ɑ,p38 and JNK pathways,1,p38,11,12,MAPK14 | p38ɑ,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,24,bortezomib,dmso,648,MAPK8,0.0657042100969808,0.330654652030404,0.172440475100638,0.00367027985593238,0.0414015366484591,1,up,JNK1,p38 and JNK pathways,1,JNK activation complex,7,8,MAPK8 | JNK1,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,24,bortezomib,dmso,648,MAPK9,0.0269507641519702,0.0915378090717074,0.0187450538760265,0.709384481540221,0.867956616590591,1,up,JNK2,p38 and JNK pathways,1,JNK activation complex,8,9,MAPK9 | JNK2,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,24,bortezomib,dmso,648,MAPKAP1,0.00817121318246588,-0.00885462759028414,-7.78589580174849e-06,0.967993874655841,0.988832250026927,-1,dn,,mTORC pathways,0,mTORC2 complex,3,3,MAPKAP1,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,24,bortezomib,dmso,648,MTOR,0.0306212635707649,0.0174258417347293,0.00984111859725045,0.635932922444486,0.827577074952233,1,up,,mTORC pathways,0,mTORC1 complex,5,5,MTOR,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,24,bortezomib,dmso,648,NFATC1,-0.0567517131852906,0.0535526171947375,0.00114065370370212,0.351016130101588,0.637760643654094,1,up,,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,25,28,NFATC1,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,24,bortezomib,dmso,648,NFKB1,-0.0124579294802618,-0.108303169683853,-0.0512957983657157,0.586795893769044,0.796841618173343,-1,dn,NF-κB,PKCθ–IKK–NF-κβ pathway,4,NFKB complex,28,32,NFKB1 | NF-κB,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,24,bortezomib,dmso,648,NFKBIA,-0.0440615293921983,0.114671495359978,0.012638475028972,0.316695360536598,0.60942691264111,1,up,IκBɑ,PKCθ–IKK–NF-κβ pathway,4,NFKB complex,26,30,NFKBIA | IκBɑ,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,24,bortezomib,dmso,648,PAG1,-0.11760993773114,-0.205313402190902,-0.160336123415868,0.000510628709127026,0.00848782828830716,-1,dn,,Initial TCR Response,5,TCR Regulator,46,51,PAG1,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,24,bortezomib,dmso,648,PDPK1,-0.0020123511774017,-0.0860898021602575,-0.0130052054852811,0.872664433099276,0.946088920444495,-1,dn,PDK1,PKCθ–IKK–NF-κβ pathway,4,CBM complex activator,35,39,PDPK1 | PDK1,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,24,bortezomib,dmso,648,PLCG1,-0.0124194902418045,0.0850435597648489,0.0146600121612273,0.779777294028249,0.900779047392349,1,up,PLC-γ1,Initial TCR Response,5,Phospholipase C complex,39,44,PLCG1 | PLC-γ1,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,24,bortezomib,dmso,648,PLCG2,-0.038952311741053,-0.182141666840035,-0.0939662722389952,0.126686889633285,0.391871245646438,-1,dn,PLC-γ2,Initial TCR Response,5,Phospholipase C complex,38,43,PLCG2 | PLC-γ2,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,24,bortezomib,dmso,648,PPP3CA,-0.0847046850504766,-0.663361497432563,-0.326322151230964,3.57029755681613e-08,1.8051254433093e-06,-1,dn,,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,24,27,PPP3CA,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,24,bortezomib,dmso,648,PPP3CB,-0.00354636661947951,-0.140020036879914,-0.0513150063055995,0.490178925548464,0.736076846882085,-1,dn,,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,23,26,PPP3CB,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,24,bortezomib,dmso,648,PPP3CC,0.100626674607742,0.0729587987278739,0.0888281870752352,0.00346338700397471,0.0395403349620446,1,up,,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,22,25,PPP3CC,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,24,bortezomib,dmso,648,PRKCQ,-0.0136983127507998,-0.0964518491808568,-0.0422548321782616,0.698878849255754,0.862550778020444,-1,dn,PKC-Θ,PKCθ–IKK–NF-κβ pathway,4,CBM complex activator,37,41,PRKCQ | PKC-Θ,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,24,bortezomib,dmso,648,PTPN22,-0.0309784089009641,-0.480053139271879,-0.163900276240847,0.000602841025005661,0.0097720069969429,-1,dn,Lyp/Pep,Initial TCR Response,5,TCR Negative Regulator,47,52,PTPN22 | Lyp/Pep,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,24,bortezomib,dmso,648,PTPRC,-0.197949395369236,-1.11886542687453,-0.234654514960976,7.01711719149765e-11,4.92590028302322e-09,-1,dn,CD45,Initial TCR Response,5,TCR Activator,49,54,PTPRC | CD45,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,24,bortezomib,dmso,648,PTPRJ,-0.00625422280298036,-0.115222994521077,-0.0435410076653094,0.619335075084312,0.81841081969085,-1,dn,CD148,Initial TCR Response,5,TCR Activator,50,55,PTPRJ | CD148,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,24,bortezomib,dmso,648,RAF1,0.0703399991857247,0.0406055129999625,0.0382111957524152,0.081768332605656,0.314841440232295,1,up,c-RAF,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,16,18,RAF1 | c-RAF,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,24,bortezomib,dmso,648,RASGRP1,-0.019219545681695,-0.0718805071806981,-0.0400959282592013,0.667111622334681,0.844603684619284,-1,dn,,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,18,20,RASGRP1,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,24,bortezomib,dmso,648,RICTOR,-0.00930006503953408,0.146763713149419,0.0472432373497089,0.470651886190996,0.7235687097387,1,up,,mTORC pathways,0,mTORC2 complex,1,1,RICTOR,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,24,bortezomib,dmso,648,RPTOR,0.083813712530033,0.591332188999159,0.24501279967691,5.17669311602613e-08,2.51278010376303e-06,1,up,,mTORC pathways,0,mTORC1 complex,4,4,RPTOR,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,24,bortezomib,dmso,648,SOS1,-0.250142109363742,-0.508620837267369,-0.291380851254226,1.78245498328848e-10,1.192139577012e-08,-1,dn,,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,17,19,SOS1,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,24,bortezomib,dmso,648,TRAC,-0.0413941836988662,-0.24955322904116,-0.119337690692721,0.0320215697284477,0.177888301683084,-1,dn,TCRɑ,Initial TCR Response,5,TCR complex,58,63,TRAC | TCRɑ,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,24,bortezomib,dmso,648,TRAF6,0.0439049911518635,0.0683825694069309,0.0196854487470796,0.451280017425925,0.711163723194027,1,up,,PKCθ–IKK–NF-κβ pathway,4,CBM complex,32,36,TRAF6,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,24,bortezomib,dmso,648,TRBC1,-0.042507905931882,-0.2912405516584,-0.0998724694148465,0.0458231522862846,0.22010784217163,-1,dn,TCRβ,Initial TCR Response,5,TCR complex,59,64,TRBC1 | TCRβ,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,24,bortezomib,dmso,648,TXK,-0.126842572431002,-0.297850549814446,-0.209164828955617,0.000395840386496216,0.00694683521260094,-1,dn,,Initial TCR Response,5,Phospholipase C complex,40,45,TXK,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,24,bortezomib,dmso,648,ZAP70,-0.00863145624802323,-0.352289503210804,-0.0646380215271827,0.0674582775955243,0.277880994130157,-1,dn,,Initial TCR Response,5,TCR Output,45,50,ZAP70,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_em,24,bortezomib,dmso,180,BCL10,0.0235132856203039,-0.0705059483817232,-0.00542498804627591,0.935086046096398,0.990899592048215,-1,dn,,PKCθ–IKK–NF-κβ pathway,4,CBM complex,36,40,BCL10,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,24,bortezomib,dmso,180,CARD11,0.118171180298715,0.28965818687054,0.191681397567193,0.0885714258928182,0.527629970947298,1,up,CARMA1,PKCθ–IKK–NF-κβ pathway,4,CBM complex,34,38,CARD11 | CARMA1,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,24,bortezomib,dmso,180,CD247,0.154405741819614,-0.482157423718163,-0.0131045616872394,0.0133661460655356,0.212753861900114,-1,dn,CD3ζ,Initial TCR Response,5,TCR complex,56,61,CD247 | CD3ζ,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,24,bortezomib,dmso,180,CD3D,-0.00395604561971149,-0.222799934167195,-0.0941522596966863,0.569889010146313,0.907708518679122,-1,dn,CD3δ,Initial TCR Response,5,TCR complex,60,65,CD3D | CD3δ,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,24,bortezomib,dmso,180,CD3E,0.00802881155389313,0.0317504705713457,0.0113839549891099,0.977993297717993,0.996870227610017,1,up,CD3ε,Initial TCR Response,5,TCR complex,61,66,CD3E | CD3ε,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,24,bortezomib,dmso,180,CD3G,-0.111845237723826,-0.437498471402527,-0.184342205408152,0.031751500914517,0.340999603733498,-1,dn,CD3γ,Initial TCR Response,5,TCR complex,57,62,CD3G | CD3γ,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,24,bortezomib,dmso,180,CD4,0.0412352651118366,-0.59402748245306,-0.161610549613395,0.0434578458198058,0.392066376161055,-1,dn,,Initial TCR Response,5,TCR Coreceptor,55,60,CD4,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,24,bortezomib,dmso,180,CHUK,0.147963009463191,0.403618280952657,0.0722524945217244,0.157134374161518,0.654865900291055,1,up,IKKɑ,PKCθ–IKK–NF-κβ pathway,4,IKb Kinase complex,30,34,CHUK | IKKɑ,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,24,bortezomib,dmso,180,CSK,-0.0147243537320675,-0.253191781740249,-0.0400114360165214,0.715011772202145,0.94127700910257,-1,dn,,Initial TCR Response,5,TCR Negative Regulator,48,53,CSK,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,24,bortezomib,dmso,180,DGKA,-0.15127746819576,0.00484716647441376,-0.0446541719152253,0.0117652037669702,0.201840777551292,-1,dn,DGKɑ,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,19,22,DGKA | DGKɑ,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,24,bortezomib,dmso,180,ELK1,-0.0545090204459497,-0.957515834633544,-0.0616613097357599,0.139616619405812,0.628085399616706,-1,dn,,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,12,14,ELK1,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,24,bortezomib,dmso,180,FOS,-0.0667774803213668,-1.45845217065658,-0.0706505993544769,0.0257202373935702,0.312296808993664,-1,dn,c-Fos,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,20,23,FOS | c-Fos,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,24,bortezomib,dmso,180,FYN,-0.0896523865042014,-0.400556064590016,-0.201338285515888,0.116996702646768,0.584053944840633,-1,dn,,Initial TCR Response,5,ITAM-targeting Kinase,51,56,FYN,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,24,bortezomib,dmso,180,GRAP2,-0.118827082876885,-0.179802592842747,-0.150244040657138,0.133685976313231,0.619969169720872,-1,dn,GADS,Initial TCR Response,5,Phospholipase C complex,42,47,GRAP2 | GADS,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,24,bortezomib,dmso,180,IKBKB,0.00389294632932545,0.466964095635622,0.125752061831182,0.169549877075449,0.669717975622938,1,up,IKKβ,PKCθ–IKK–NF-κβ pathway,4,IKb Kinase complex,31,35,IKBKB | IKKβ,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,24,bortezomib,dmso,180,ITK,-0.103759589093862,-1.19297991319802,-0.561764288971408,1.01283538045785e-07,1.95288793938978e-05,-1,dn,,Initial TCR Response,5,Phospholipase C complex,41,46,ITK,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,24,bortezomib,dmso,180,JUN,-0.0263101510329943,-0.532412258881781,-0.165523335954904,0.0982797182628243,0.552057685716176,-1,dn,c-Jun,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,21,24,JUN | c-Jun,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,24,bortezomib,dmso,180,LAT,-0.0517518877238726,-0.723215013060308,-0.1648182742328,0.0192019796206104,0.261903440280041,-1,dn,,Initial TCR Response,5,Phospholipase C complex,43,48,LAT,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,24,bortezomib,dmso,180,LCK,0.0495318501679029,-0.9438232346887,-0.316926891719651,0.000140603580687328,0.00925080512637485,-1,dn,,Initial TCR Response,5,ITAM-targeting Kinase,52,57,LCK,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,24,bortezomib,dmso,180,LCP2,-0.0940186183094118,-0.754506116740942,-0.360753553800417,0.000561874757421894,0.0275651101407392,-1,dn,SLP-76,Initial TCR Response,5,Phospholipase C complex,44,49,LCP2 | SLP-76,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,24,bortezomib,dmso,180,MALT1,0.0621709269344675,0.00686525776192681,0.0273380649715876,0.625462669652405,0.922368916819539,1,up,,PKCθ–IKK–NF-κβ pathway,4,CBM complex,33,37,MALT1,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,24,bortezomib,dmso,180,MAP2K1,0.194791122482011,0.239977552461892,0.148451913664451,0.0170942912461358,0.249962555064747,1,up,MEK1,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,15,17,MAP2K1 | MEK1,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,24,bortezomib,dmso,180,MAP2K2,0.0854933005266037,0.890082493138371,0.140809058077275,0.00966208159607897,0.1816515159027,1,up,MEK2,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,14,16,MAP2K2 | MEK2,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,24,bortezomib,dmso,180,MAP2K7,-0.0303566775432252,-0.286150615823992,-0.0221140377046842,0.755183255605523,0.949067020601655,-1,dn,MKK7,p38 and JNK pathways,1,JNK activation complex,9,10,MAP2K7 | MKK7,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,24,bortezomib,dmso,180,MAP3K7,-0.0160624655535917,-0.129838628946772,-0.0472639663054462,0.824139604449067,0.964283030559524,-1,dn,TAK1,p38 and JNK pathways,1,JNK activation complex,10,11,MAP3K7 | TAK1,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,24,bortezomib,dmso,180,MAPK1,0.0129871117871909,0.230014193793202,0.0865994691992138,0.572158731747831,0.908501123583804,1,up,ERK2,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,13,15,MAPK1 | ERK2,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,24,bortezomib,dmso,180,MAPK14,0.0191227860171422,-0.293755768090462,-0.102312301137606,0.400871415407872,0.853086474626968,-1,dn,p38ɑ,p38 and JNK pathways,1,p38,11,12,MAPK14 | p38ɑ,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,24,bortezomib,dmso,180,MAPK8,0.133641647011041,0.561292908960698,0.298024623616137,0.0118111030086119,0.201840777551292,1,up,JNK1,p38 and JNK pathways,1,JNK activation complex,7,8,MAPK8 | JNK1,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,24,bortezomib,dmso,180,MAPK9,0.00781215078699381,0.0999483634963053,0.0177131931276026,0.94628321520121,0.992833528646757,1,up,JNK2,p38 and JNK pathways,1,JNK activation complex,8,9,MAPK9 | JNK2,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,24,bortezomib,dmso,180,MAPKAP1,0.013068772344228,0.031847499852706,0.0169940802130152,0.966704269195216,0.996261499018812,1,up,,mTORC pathways,0,mTORC2 complex,3,3,MAPKAP1,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,24,bortezomib,dmso,180,MTOR,-0.0708084228597566,0.268799097663167,0.052678874390699,0.358214540462048,0.836296964592446,1,up,,mTORC pathways,0,mTORC1 complex,5,5,MTOR,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,24,bortezomib,dmso,180,NFATC1,-0.0393940374093947,0.472349017486181,0.0579034391945766,0.324240532932792,0.817790054724238,1,up,,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,25,28,NFATC1,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,24,bortezomib,dmso,180,NFKB1,-0.0528734280419099,-0.197146371763218,-0.110673373496092,0.465379441043856,0.884156953642212,-1,dn,NF-κB,PKCθ–IKK–NF-κβ pathway,4,NFKB complex,28,32,NFKB1 | NF-κB,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,24,bortezomib,dmso,180,NFKBIA,0.0270109771824864,0.373665836064784,0.0747388205781937,0.37650546469547,0.843199582809417,1,up,IκBɑ,PKCθ–IKK–NF-κβ pathway,4,NFKB complex,26,30,NFKBIA | IκBɑ,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,24,bortezomib,dmso,180,PAG1,-0.106769506325418,-0.806102901010177,-0.332716169741969,0.00267599142974747,0.0830960484795367,-1,dn,,Initial TCR Response,5,TCR Regulator,46,51,PAG1,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,24,bortezomib,dmso,180,PDPK1,0.012280301433737,-0.183437483075874,-0.0289597029211306,0.815400151921695,0.963437032639596,-1,dn,PDK1,PKCθ–IKK–NF-κβ pathway,4,CBM complex activator,35,39,PDPK1 | PDK1,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,24,bortezomib,dmso,180,PLCG1,0.0521660470536769,0.134807744116322,0.0311326981542337,0.660388671016714,0.929886130392998,1,up,PLC-γ1,Initial TCR Response,5,Phospholipase C complex,39,44,PLCG1 | PLC-γ1,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,24,bortezomib,dmso,180,PLCG2,0.00285694464032812,0.139946108826544,0.0580659812469531,0.803790057943709,0.960402014556412,1,up,PLC-γ2,Initial TCR Response,5,Phospholipase C complex,38,43,PLCG2 | PLC-γ2,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,24,bortezomib,dmso,180,PPP3CA,-0.087400640025348,-0.639872260694311,-0.333791977071754,0.00883107250751232,0.172278640375964,-1,dn,,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,24,27,PPP3CA,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,24,bortezomib,dmso,180,PPP3CB,0.0184226290235187,-0.2759715322704,-0.0878358031927874,0.450838973825693,0.878205759764659,-1,dn,,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,23,26,PPP3CB,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,24,bortezomib,dmso,180,PPP3CC,0.0887445265520173,0.179451576474844,0.125717705376603,0.276221496043142,0.782506428674568,1,up,,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,22,25,PPP3CC,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,24,bortezomib,dmso,180,PRKCQ,0.0373661382302394,-0.0188462279418529,0.0206846865995371,0.831708193110071,0.965242529265901,1,up,PKC-Θ,PKCθ–IKK–NF-κβ pathway,4,CBM complex activator,37,41,PRKCQ | PKC-Θ,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,24,bortezomib,dmso,180,PRR5,-0.00547124281770579,-0.113820585834812,-0.00756638394730742,0.966048282460755,0.996261499018812,-1,dn,,mTORC pathways,0,mTORC2 complex,2,2,PRR5,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,24,bortezomib,dmso,180,PTPN22,-0.129919618923061,-0.39271248854717,-0.120850000711661,0.141928206788742,0.630666264205627,-1,dn,Lyp/Pep,Initial TCR Response,5,TCR Negative Regulator,47,52,PTPN22 | Lyp/Pep,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,24,bortezomib,dmso,180,PTPRC,-0.326261923208812,-1.58617362994002,-0.425709042473966,3.27233381115675e-09,1.13045498451252e-06,-1,dn,CD45,Initial TCR Response,5,TCR Activator,49,54,PTPRC | CD45,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,24,bortezomib,dmso,180,PTPRJ,0.0680621198433322,-0.363255383548874,-0.0919906409303154,0.247237150221113,0.75947734347772,-1,dn,CD148,Initial TCR Response,5,TCR Activator,50,55,PTPRJ | CD148,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,24,bortezomib,dmso,180,RAF1,0.127481980432735,-0.0201071781454499,0.0349663754131891,0.149425450486875,0.641671096874008,1,up,c-RAF,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,16,18,RAF1 | c-RAF,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,24,bortezomib,dmso,180,RASGRP1,0.0141730203114819,0.0961892624899404,0.048807306967642,0.87934611603861,0.977061729529749,1,up,,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,18,20,RASGRP1,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,24,bortezomib,dmso,180,RELA,0.0265534227645447,0.988770051907563,0.0513907618722807,0.173132100392718,0.674231209185543,1,up,p65,PKCθ–IKK–NF-κβ pathway,4,NFKB complex,27,31,RELA | p65,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,24,bortezomib,dmso,180,RICTOR,0.148929550831546,-0.154652348773164,0.0445937076978224,0.0354922993945479,0.354923169655368,1,up,,mTORC pathways,0,mTORC2 complex,1,1,RICTOR,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,24,bortezomib,dmso,180,RPTOR,0.224822468222259,0.815405064925378,0.370055404017109,1.36553327269518e-06,0.000179708513712948,1,up,,mTORC pathways,0,mTORC1 complex,4,4,RPTOR,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,24,bortezomib,dmso,180,SOS1,-0.290612574623367,-0.62359500857317,-0.352292633613258,0.000136574608482371,0.00913177483005917,-1,dn,,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,17,19,SOS1,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,24,bortezomib,dmso,180,TRAC,-0.0353947425955716,-0.225558722290582,-0.104710609194669,0.49663635069662,0.8908709378005,-1,dn,TCRɑ,Initial TCR Response,5,TCR complex,58,63,TRAC | TCRɑ,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,24,bortezomib,dmso,180,TRAF6,-0.0107528245098534,0.152479440163954,0.0235003756444144,0.882242393358086,0.978141368678019,1,up,,PKCθ–IKK–NF-κβ pathway,4,CBM complex,32,36,TRAF6,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,24,bortezomib,dmso,180,TRBC1,0.000655480697663267,-0.453483349380531,-0.137206655515686,0.180970975774277,0.686057675012826,-1,dn,TCRβ,Initial TCR Response,5,TCR complex,59,64,TRBC1 | TCRβ,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,24,bortezomib,dmso,180,TXK,-0.151816714883767,-0.0406656984704452,-0.0784170400908534,0.201810375697024,0.714768082245163,-1,dn,,Initial TCR Response,5,Phospholipase C complex,40,45,TXK,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,24,bortezomib,dmso,180,ZAP70,-0.0815460508680932,-0.0324798015693993,-0.0233196585552038,0.241640260012322,0.757444005959228,-1,dn,,Initial TCR Response,5,TCR Output,45,50,ZAP70,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_naive,24,bortezomib,dmso,1352,BCL10,0.0439885272643473,0.0932617003686686,0.0106301450540092,0.403700877973498,0.73387889522202,1,up,,PKCθ–IKK–NF-κβ pathway,4,CBM complex,36,40,BCL10,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,24,bortezomib,dmso,1352,CARD11,0.0301678534055805,0.176166450286757,0.0935890866375562,0.0378689264742881,0.260731298077011,1,up,CARMA1,PKCθ–IKK–NF-κβ pathway,4,CBM complex,34,38,CARD11 | CARMA1,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,24,bortezomib,dmso,1352,CD247,-0.026923501183397,-0.204853928337738,-0.0740075493529391,0.095539704972417,0.407231584098165,-1,dn,CD3ζ,Initial TCR Response,5,TCR complex,56,61,CD247 | CD3ζ,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,24,bortezomib,dmso,1352,CD3D,0.0219199147784113,0.0482169645309345,0.0313459149525376,0.440792887907508,0.757434663647603,1,up,CD3δ,Initial TCR Response,5,TCR complex,60,65,CD3D | CD3δ,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,24,bortezomib,dmso,1352,CD3E,-0.0177683377933789,-0.150343504442612,-0.0535290345173237,0.138294074305439,0.490833602092454,-1,dn,CD3ε,Initial TCR Response,5,TCR complex,61,66,CD3E | CD3ε,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,24,bortezomib,dmso,1352,CD3G,-0.0162269101702579,-0.153413873675512,-0.0632158409460361,0.124482238551868,0.464612539996508,-1,dn,CD3γ,Initial TCR Response,5,TCR complex,57,62,CD3G | CD3γ,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,24,bortezomib,dmso,1352,CD4,-0.00866523701596246,-0.315256591995945,-0.0898906722170126,0.00275604621597718,0.0478255078654864,-1,dn,,Initial TCR Response,5,TCR Coreceptor,55,60,CD4,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,24,bortezomib,dmso,1352,CHUK,0.0260046440297619,0.119443384472536,0.0144813589456633,0.557550575477796,0.818506082611722,1,up,IKKɑ,PKCθ–IKK–NF-κβ pathway,4,IKb Kinase complex,30,34,CHUK | IKKɑ,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,24,bortezomib,dmso,1352,CSK,0.00806631583846526,-0.178046499323349,-0.0248518569317069,0.334061105693157,0.687417905187625,-1,dn,,Initial TCR Response,5,TCR Negative Regulator,48,53,CSK,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,24,bortezomib,dmso,1352,DGKA,-0.0670197051510199,-0.0934379943294277,-0.0676682003842216,0.00171141928175946,0.0345436470818292,-1,dn,DGKɑ,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,19,22,DGKA | DGKɑ,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,24,bortezomib,dmso,1352,FYN,-0.0197822090386478,-0.165676921703157,-0.0772577430481642,0.130453244523902,0.475176328905847,-1,dn,,Initial TCR Response,5,ITAM-targeting Kinase,51,56,FYN,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,24,bortezomib,dmso,1352,GRAP2,-0.0434243776045788,-0.229942970893806,-0.126964630214587,0.00283385379500626,0.0486256344691231,-1,dn,GADS,Initial TCR Response,5,Phospholipase C complex,42,47,GRAP2 | GADS,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,24,bortezomib,dmso,1352,IKBKB,-0.0166666197894514,-0.0652508500998654,-0.0215496949582999,0.606332413840501,0.847277510985164,-1,dn,IKKβ,PKCθ–IKK–NF-κβ pathway,4,IKb Kinase complex,31,35,IKBKB | IKKβ,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,24,bortezomib,dmso,1352,ITK,-0.0610403620023417,-0.302808927979102,-0.170547308960652,2.65046571552417e-05,0.00121006381178991,-1,dn,,Initial TCR Response,5,Phospholipase C complex,41,46,ITK,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,24,bortezomib,dmso,1352,JUN,-0.0250486343648186,-0.127812505115145,-0.027822293489841,0.39907525201302,0.731322694599377,-1,dn,c-Jun,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,21,24,JUN | c-Jun,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,24,bortezomib,dmso,1352,LAT,-0.00720244018017416,-0.160889344379389,-0.0419923631065252,0.223893343482808,0.588304879929132,-1,dn,,Initial TCR Response,5,Phospholipase C complex,43,48,LAT,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,24,bortezomib,dmso,1352,LCK,0.0290429353617415,0.0310515205425801,0.0206112874533531,0.450476536345991,0.761550591530472,1,up,,Initial TCR Response,5,ITAM-targeting Kinase,52,57,LCK,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,24,bortezomib,dmso,1352,LCP2,-0.0159738986551066,-0.0465472044899404,-0.0290077577023531,0.633991862138188,0.859103821769003,-1,dn,SLP-76,Initial TCR Response,5,Phospholipase C complex,44,49,LCP2 | SLP-76,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,24,bortezomib,dmso,1352,MALT1,0.00939425688124189,-0.0278250361188741,-0.00786650638312336,0.874461930988472,0.951364966054125,-1,dn,,PKCθ–IKK–NF-κβ pathway,4,CBM complex,33,37,MALT1,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,24,bortezomib,dmso,1352,MAP2K1,0.0559787943348481,0.107093755717494,0.0409182390754107,0.0711216291826774,0.353513558141901,1,up,MEK1,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,15,17,MAP2K1 | MEK1,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,24,bortezomib,dmso,1352,MAP2K2,-0.0149394770541521,-0.165940941851008,-0.0194668190898294,0.386803372900021,0.723076253995408,-1,dn,MEK2,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,14,16,MAP2K2 | MEK2,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,24,bortezomib,dmso,1352,MAP2K7,0.00317634959417001,-0.225148708434261,-0.0207007626009105,0.344064955340401,0.69578651767677,-1,dn,MKK7,p38 and JNK pathways,1,JNK activation complex,9,10,MAP2K7 | MKK7,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,24,bortezomib,dmso,1352,MAP3K7,0.0282830821773532,0.0517237067933582,0.0254794228118614,0.400487565364118,0.731668563320545,1,up,TAK1,p38 and JNK pathways,1,JNK activation complex,10,11,MAP3K7 | TAK1,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,24,bortezomib,dmso,1352,MAPK1,0.00628660492878327,0.0464324892636726,0.0191065222545954,0.823394563955189,0.933674949447863,1,up,ERK2,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,13,15,MAPK1 | ERK2,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,24,bortezomib,dmso,1352,MAPK14,0.0303754192272061,0.00685410551373178,0.0143080800034789,0.418883417934024,0.742680493655563,1,up,p38ɑ,p38 and JNK pathways,1,p38,11,12,MAPK14 | p38ɑ,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,24,bortezomib,dmso,1352,MAPK8,0.0356877042423577,0.166119287956441,0.0942059792733524,0.0500545582884829,0.296119941011548,1,up,JNK1,p38 and JNK pathways,1,JNK activation complex,7,8,MAPK8 | JNK1,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,24,bortezomib,dmso,1352,MAPK9,-0.0377955006214004,0.15306560150612,0.0219563543254868,0.175000060193947,0.537820779126215,1,up,JNK2,p38 and JNK pathways,1,JNK activation complex,8,9,MAPK9 | JNK2,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,24,bortezomib,dmso,1352,MAPKAP1,0.0570124553094498,0.0162716730620233,0.0257573008740334,0.071014311299723,0.353513558141901,1,up,,mTORC pathways,0,mTORC2 complex,3,3,MAPKAP1,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,24,bortezomib,dmso,1352,MTOR,0.0253459371817569,0.307940345825569,0.0764612339685559,0.00570762582863092,0.0832271675011391,1,up,,mTORC pathways,0,mTORC1 complex,5,5,MTOR,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,24,bortezomib,dmso,1352,NFATC1,0.00127691028220709,0.256794906527757,0.0359017408945842,0.128988965672949,0.472333492477851,1,up,,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,25,28,NFATC1,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,24,bortezomib,dmso,1352,NFKB1,0.0573334700413217,-0.00254633108185139,0.0231592839288474,0.0760777487948811,0.363788237691233,1,up,NF-κB,PKCθ–IKK–NF-κβ pathway,4,NFKB complex,28,32,NFKB1 | NF-κB,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,24,bortezomib,dmso,1352,NFKBIA,-0.00309188004934791,-0.0074204374261281,-0.00109340852005493,0.995133883605766,0.997289155123377,-1,dn,IκBɑ,PKCθ–IKK–NF-κβ pathway,4,NFKB complex,26,30,NFKBIA | IκBɑ,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,24,bortezomib,dmso,1352,PAG1,-0.0042915319892258,-0.126262497172343,-0.0574229545500784,0.291964172553872,0.654992049704747,-1,dn,,Initial TCR Response,5,TCR Regulator,46,51,PAG1,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,24,bortezomib,dmso,1352,PDPK1,0.0194136284722905,0.131762095214504,0.0199337523175678,0.376772080260616,0.71654893518446,1,up,PDK1,PKCθ–IKK–NF-κβ pathway,4,CBM complex activator,35,39,PDPK1 | PDK1,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,24,bortezomib,dmso,1352,PLCG1,0.0389564499065815,0.0476197964023058,0.0185831545392444,0.192853892777181,0.558281870568273,1,up,PLC-γ1,Initial TCR Response,5,Phospholipase C complex,39,44,PLCG1 | PLC-γ1,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,24,bortezomib,dmso,1352,PLCG2,0.00361816039100313,0.0601173649006915,0.0295093557333825,0.731949673227107,0.897674127542679,1,up,PLC-γ2,Initial TCR Response,5,Phospholipase C complex,38,43,PLCG2 | PLC-γ2,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,24,bortezomib,dmso,1352,PPP3CA,-0.0377822741297594,-0.105276889847944,-0.0703222418128302,0.154305131578706,0.512899608279711,-1,dn,,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,24,27,PPP3CA,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,24,bortezomib,dmso,1352,PPP3CB,0.0372089063536272,-0.26619075467678,-0.0785045669455178,0.00273094247091265,0.0474973441086168,-1,dn,,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,23,26,PPP3CB,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,24,bortezomib,dmso,1352,PPP3CC,0.000303735367598137,-0.0266283751242373,-0.0114559508903267,0.945035301020349,0.978570049231594,-1,dn,,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,22,25,PPP3CC,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,24,bortezomib,dmso,1352,PRKCQ,0.0371782887742863,0.0651387869883863,0.0528442211320588,0.197710140761399,0.564687781895407,1,up,PKC-Θ,PKCθ–IKK–NF-κβ pathway,4,CBM complex activator,37,41,PRKCQ | PKC-Θ,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,24,bortezomib,dmso,1352,PTPN22,0.0972769416265307,-0.314929003083481,-0.0545995470745586,0.000214008588540132,0.00736074383005746,-1,dn,Lyp/Pep,Initial TCR Response,5,TCR Negative Regulator,47,52,PTPN22 | Lyp/Pep,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,24,bortezomib,dmso,1352,PTPRC,-0.0924685017752649,-0.279879884373028,-0.109748135568481,3.70111335417026e-05,0.00160963284986415,-1,dn,CD45,Initial TCR Response,5,TCR Activator,49,54,PTPRC | CD45,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,24,bortezomib,dmso,1352,PTPRJ,-0.000875931266879108,-0.115400531788273,-0.0356248115733546,0.448756330005422,0.760641564312078,-1,dn,CD148,Initial TCR Response,5,TCR Activator,50,55,PTPRJ | CD148,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,24,bortezomib,dmso,1352,RAF1,0.00977090700873913,0.141494834852999,0.0539381854829248,0.222952519710941,0.587039418531727,1,up,c-RAF,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,16,18,RAF1 | c-RAF,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,24,bortezomib,dmso,1352,RASGRP1,0.0108142311480609,-0.092077880343094,-0.0345656908251223,0.449041709075274,0.760641564312078,-1,dn,,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,18,20,RASGRP1,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,24,bortezomib,dmso,1352,RICTOR,0.0468457493527734,0.0962105158203687,0.0721215524818573,0.0567126253485813,0.31804701067812,1,up,,mTORC pathways,0,mTORC2 complex,1,1,RICTOR,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,24,bortezomib,dmso,1352,RPTOR,0.0699508807434573,0.164412136720856,0.0826987791447404,0.000827172545128317,0.0205320822690427,1,up,,mTORC pathways,0,mTORC1 complex,4,4,RPTOR,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,24,bortezomib,dmso,1352,SOS1,-0.137505251189653,-0.214691196776421,-0.176674608798894,9.18203612319513e-08,7.18634868009251e-06,-1,dn,,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,17,19,SOS1,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,24,bortezomib,dmso,1352,TRAC,-0.00172771830476032,-0.227745337545375,-0.0925524086603743,0.0145612060656647,0.152390196219381,-1,dn,TCRɑ,Initial TCR Response,5,TCR complex,58,63,TRAC | TCRɑ,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,24,bortezomib,dmso,1352,TRAF6,-0.0227517275969602,0.126881180913932,0.0145586534763888,0.440862588612096,0.757434663647603,1,up,,PKCθ–IKK–NF-κβ pathway,4,CBM complex,32,36,TRAF6,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,24,bortezomib,dmso,1352,TRBC1,-0.0752416787909016,-0.317979412350608,-0.131515534007128,0.000134965564061086,0.00489717247730709,-1,dn,TCRβ,Initial TCR Response,5,TCR complex,59,64,TRBC1 | TCRβ,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,24,bortezomib,dmso,1352,TXK,0.0220196978199417,-0.220465463833048,-0.0529083570003812,0.0612728123624553,0.330029825014067,-1,dn,,Initial TCR Response,5,Phospholipase C complex,40,45,TXK,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,24,bortezomib,dmso,1352,ZAP70,-0.0198019279446951,-0.034114091914682,-0.00860866841029778,0.640376454615413,0.860695115592296,-1,dn,,Initial TCR Response,5,TCR Output,45,50,ZAP70,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_treg,24,bortezomib,dmso,78,BCL10,0.0219964408924089,0.496765130752359,0.050658373653452,0.67399765459719,0.999998222324989,1,up,,PKCθ–IKK–NF-κβ pathway,4,CBM complex,36,40,BCL10,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,24,bortezomib,dmso,78,CARD11,0.101517158804119,0.306651099991149,0.174041363176123,0.45056279174468,0.999998222324989,1,up,CARMA1,PKCθ–IKK–NF-κβ pathway,4,CBM complex,34,38,CARD11 | CARMA1,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,24,bortezomib,dmso,78,CD247,-0.137273801523178,0.328929656644188,-0.07008367665598,0.336040464352786,0.999998222324989,-1,dn,CD3ζ,Initial TCR Response,5,TCR complex,56,61,CD247 | CD3ζ,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,24,bortezomib,dmso,78,CD3D,0.0558716348589678,0.162346978999953,0.101441327292907,0.709536185785302,0.999998222324989,1,up,CD3δ,Initial TCR Response,5,TCR complex,60,65,CD3D | CD3δ,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,24,bortezomib,dmso,78,CD3E,-0.00925914497514839,-0.969571979594138,-0.30230666292794,0.0242154039610706,0.532047807241223,-1,dn,CD3ε,Initial TCR Response,5,TCR complex,61,66,CD3E | CD3ε,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,24,bortezomib,dmso,78,CD3G,-0.0875891744764902,-0.913744617826755,-0.363073618768469,0.0188039545685746,0.524463463182979,-1,dn,CD3γ,Initial TCR Response,5,TCR complex,57,62,CD3G | CD3γ,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,24,bortezomib,dmso,78,CD4,-0.183876256049767,-0.147998762683426,-0.0887075985919155,0.282150361453699,0.999998222324989,-1,dn,,Initial TCR Response,5,TCR Coreceptor,55,60,CD4,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,24,bortezomib,dmso,78,CHUK,0.206929376005396,0.10929418683323,0.0395128953014294,0.434456934964445,0.999998222324989,1,up,IKKɑ,PKCθ–IKK–NF-κβ pathway,4,IKb Kinase complex,30,34,CHUK | IKKɑ,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,24,bortezomib,dmso,78,CSK,0.113694734697557,-0.283458401405303,-0.0396454343411153,0.395700207106394,0.999998222324989,-1,dn,,Initial TCR Response,5,TCR Negative Regulator,48,53,CSK,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,24,bortezomib,dmso,78,DGKA,0.0929310131196567,-0.12419932281785,-0.0134900755830399,0.540320731539668,0.999998222324989,-1,dn,DGKɑ,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,19,22,DGKA | DGKɑ,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,24,bortezomib,dmso,78,ELK1,-0.100420945738391,1.19790098311727,0.0471851072117938,0.37010042328734,0.999998222324989,1,up,,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,12,14,ELK1,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,24,bortezomib,dmso,78,FYN,-0.260392698391446,-0.505581159152437,-0.381297765566456,0.0239019783303427,0.532047807241223,-1,dn,,Initial TCR Response,5,ITAM-targeting Kinase,51,56,FYN,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,24,bortezomib,dmso,78,GRAP2,-0.102677646834856,-0.954719064545214,-0.417869493125035,0.0160845459019137,0.489182422065494,-1,dn,GADS,Initial TCR Response,5,Phospholipase C complex,42,47,GRAP2 | GADS,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,24,bortezomib,dmso,78,IKBKB,-0.0349825844132199,-0.20570559725174,-0.046194569631643,0.861847473774719,0.999998222324989,-1,dn,IKKβ,PKCθ–IKK–NF-κβ pathway,4,IKb Kinase complex,31,35,IKBKB | IKKβ,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,24,bortezomib,dmso,78,IKBKG,0.0659756394563611,0.214316351357207,0.020059752130486,0.925030944241893,0.999998222324989,1,up,IKKγ,PKCθ–IKK–NF-κβ pathway,4,IKb Kinase complex,29,33,IKBKG | IKKγ,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,24,bortezomib,dmso,78,ITK,-0.106407676265703,-0.877050259364083,-0.447054390424471,0.0181177059459745,0.52354774149384,-1,dn,,Initial TCR Response,5,Phospholipase C complex,41,46,ITK,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,24,bortezomib,dmso,78,JUN,-0.0579306954918143,0.0892830886806034,0.00941721115930999,0.940961790460009,0.999998222324989,1,up,c-Jun,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,21,24,JUN | c-Jun,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,24,bortezomib,dmso,78,LAT,-0.0758151314972465,-0.804573563392269,-0.23032445946225,0.0840029636921656,0.821545955474346,-1,dn,,Initial TCR Response,5,Phospholipase C complex,43,48,LAT,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,24,bortezomib,dmso,78,LCK,-0.098180764475397,-0.39802978380522,-0.162722303568343,0.276866349227089,0.999998222324989,-1,dn,,Initial TCR Response,5,ITAM-targeting Kinase,52,57,LCK,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,24,bortezomib,dmso,78,LCP2,-0.188109506715457,-0.355922458708742,-0.227294970316025,0.0780834217548741,0.800874293789698,-1,dn,SLP-76,Initial TCR Response,5,Phospholipase C complex,44,49,LCP2 | SLP-76,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,24,bortezomib,dmso,78,MALT1,-0.0869489911525486,0.636988302954811,0.221116755368995,0.0967784491817218,0.861502131496443,1,up,,PKCθ–IKK–NF-κβ pathway,4,CBM complex,33,37,MALT1,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,24,bortezomib,dmso,78,MAP2K1,0.172544969175509,0.368298537047336,0.134080955371126,0.24871495536724,0.999998222324989,1,up,MEK1,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,15,17,MAP2K1 | MEK1,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,24,bortezomib,dmso,78,MAP2K2,0.00244206139214415,-0.356289734465747,-0.0333274690829333,0.826787624852313,0.999998222324989,-1,dn,MEK2,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,14,16,MAP2K2 | MEK2,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,24,bortezomib,dmso,78,MAP2K7,0.0630376102765309,0.122728840755275,0.0248434634437167,0.878948000685142,0.999998222324989,1,up,MKK7,p38 and JNK pathways,1,JNK activation complex,9,10,MAP2K7 | MKK7,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,24,bortezomib,dmso,78,MAP3K7,0.213591655588498,0.558682924520438,0.21296076328976,0.0417315131291792,0.606179640959338,1,up,TAK1,p38 and JNK pathways,1,JNK activation complex,10,11,MAP3K7 | TAK1,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,24,bortezomib,dmso,78,MAPK1,-0.0233702019411871,0.141371886085779,0.0449886720032467,0.892174962855852,0.999998222324989,1,up,ERK2,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,13,15,MAPK1 | ERK2,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,24,bortezomib,dmso,78,MAPK14,-0.0755890206195254,0.0463005446165632,-0.00918681473058469,0.7382030222085,0.999998222324989,-1,dn,p38ɑ,p38 and JNK pathways,1,p38,11,12,MAPK14 | p38ɑ,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,24,bortezomib,dmso,78,MAPK8,-0.0211459491677749,0.188367508445544,0.0829494678727778,0.827693951086469,0.999998222324989,1,up,JNK1,p38 and JNK pathways,1,JNK activation complex,7,8,MAPK8 | JNK1,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,24,bortezomib,dmso,78,MAPK9,0.0272254564796102,-0.540866281287273,-0.0937875257864114,0.4898785855168,0.999998222324989,-1,dn,JNK2,p38 and JNK pathways,1,JNK activation complex,8,9,MAPK9 | JNK2,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,24,bortezomib,dmso,78,MAPKAP1,0.119523015927748,0.0781730416975393,0.0708676053416686,0.465946535433876,0.999998222324989,1,up,,mTORC pathways,0,mTORC2 complex,3,3,MAPKAP1,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,24,bortezomib,dmso,78,MTOR,-0.0985924948518759,-0.280126432130594,-0.0770189019904761,0.552968361108448,0.999998222324989,-1,dn,,mTORC pathways,0,mTORC1 complex,5,5,MTOR,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,24,bortezomib,dmso,78,NFATC1,0.0314863932586543,0.176405053130496,0.0181603348062007,0.944490665036577,0.999998222324989,1,up,,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,25,28,NFATC1,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,24,bortezomib,dmso,78,NFKB1,0.042704150478657,0.489325712275034,0.211806566092236,0.331834027912183,0.999998222324989,1,up,NF-κB,PKCθ–IKK–NF-κβ pathway,4,NFKB complex,28,32,NFKB1 | NF-κB,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,24,bortezomib,dmso,78,NFKBIA,0.0571887982779397,0.946970722900615,0.144489025896725,0.17350884130867,0.997489890063595,1,up,IκBɑ,PKCθ–IKK–NF-κβ pathway,4,NFKB complex,26,30,NFKBIA | IκBɑ,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,24,bortezomib,dmso,78,PAG1,-0.15480245930222,-0.0202707436087891,-0.104802560560877,0.320889586305984,0.999998222324989,-1,dn,,Initial TCR Response,5,TCR Regulator,46,51,PAG1,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,24,bortezomib,dmso,78,PDPK1,0.0310726186265147,-0.121267872873636,-0.0152626054353514,0.93652164470329,0.999998222324989,-1,dn,PDK1,PKCθ–IKK–NF-κβ pathway,4,CBM complex activator,35,39,PDPK1 | PDK1,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,24,bortezomib,dmso,78,PLCG1,-0.019442675444015,-0.39625755958861,-0.0563985898102248,0.720368301770624,0.999998222324989,-1,dn,PLC-γ1,Initial TCR Response,5,Phospholipase C complex,39,44,PLCG1 | PLC-γ1,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,24,bortezomib,dmso,78,PLCG2,-0.111038545539474,0.152840009770904,0.00668464737069485,0.408048234945751,0.999998222324989,1,up,PLC-γ2,Initial TCR Response,5,Phospholipase C complex,38,43,PLCG2 | PLC-γ2,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,24,bortezomib,dmso,78,PPP3CA,-0.0666617461369929,-1.24240979504802,-0.55801285703121,0.00134507012968576,0.181253373321809,-1,dn,,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,24,27,PPP3CA,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,24,bortezomib,dmso,78,PPP3CB,0.118727957426347,-0.196380171175342,-0.0372635143132126,0.532918571428633,0.999998222324989,-1,dn,,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,23,26,PPP3CB,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,24,bortezomib,dmso,78,PPP3CC,0.0884885835802395,0.600547592325304,0.299960466229352,0.0960473957922569,0.860203619370529,1,up,,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,22,25,PPP3CC,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,24,bortezomib,dmso,78,PRKCQ,-0.053296773390852,-0.725365982801852,-0.318080054464461,0.0957528242625837,0.858459144120857,-1,dn,PKC-Θ,PKCθ–IKK–NF-κβ pathway,4,CBM complex activator,37,41,PRKCQ | PKC-Θ,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,24,bortezomib,dmso,78,PRR5,0.060977468017341,-0.0108467599236386,0.00345144381634867,0.957286193616383,0.999998222324989,1,up,,mTORC pathways,0,mTORC2 complex,2,2,PRR5,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,24,bortezomib,dmso,78,PTPN22,-0.129610587583545,-0.970501401934311,-0.243493036148251,0.0427264299113002,0.611193882951237,-1,dn,Lyp/Pep,Initial TCR Response,5,TCR Negative Regulator,47,52,PTPN22 | Lyp/Pep,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,24,bortezomib,dmso,78,PTPRC,-0.309189887353129,-0.884166142348022,-0.361889103004181,0.00388578056572599,0.265902749806203,-1,dn,CD45,Initial TCR Response,5,TCR Activator,49,54,PTPRC | CD45,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,24,bortezomib,dmso,78,PTPRJ,-0.0355292477239795,-0.301236985227451,-0.146851152128302,0.630487051460474,0.999998222324989,-1,dn,CD148,Initial TCR Response,5,TCR Activator,50,55,PTPRJ | CD148,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,24,bortezomib,dmso,78,RAF1,-0.168487275086406,0.458828820311137,0.11176012023867,0.106399287851705,0.882323622362042,1,up,c-RAF,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,16,18,RAF1 | c-RAF,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,24,bortezomib,dmso,78,RASGRP1,-0.10248607079542,-0.495289849347068,-0.261412143519779,0.198604521950406,0.999998222324989,-1,dn,,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,18,20,RASGRP1,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,24,bortezomib,dmso,78,RICTOR,0.00516415365998822,0.0575192409927725,0.0281799904772591,0.983726712066413,0.999998222324989,1,up,,mTORC pathways,0,mTORC2 complex,1,1,RICTOR,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,24,bortezomib,dmso,78,RPTOR,-0.060082997750934,0.820667849817116,0.24705379684272,0.0617457482040378,0.740864395231736,1,up,,mTORC pathways,0,mTORC1 complex,4,4,RPTOR,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,24,bortezomib,dmso,78,SOS1,-0.181030901904177,-0.292339550667221,-0.249193858106592,0.116904174996964,0.895062065704178,-1,dn,,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,17,19,SOS1,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,24,bortezomib,dmso,78,TRAC,-0.0534328337117545,0.039037004988225,-0.0160890804768488,0.829784071722456,0.999998222324989,-1,dn,TCRɑ,Initial TCR Response,5,TCR complex,58,63,TRAC | TCRɑ,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,24,bortezomib,dmso,78,TRAF6,0.16401553572762,-0.134860659591594,-0.0021902817358633,0.549790013033121,0.999998222324989,-1,dn,,PKCθ–IKK–NF-κβ pathway,4,CBM complex,32,36,TRAF6,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,24,bortezomib,dmso,78,TRBC1,-0.153238493511812,-0.491102653708109,-0.250535615119978,0.172693389901479,0.996456786658141,-1,dn,TCRβ,Initial TCR Response,5,TCR complex,59,64,TRBC1 | TCRβ,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,24,bortezomib,dmso,78,TXK,-0.0314200796226561,0.249868015276619,0.120136170738921,0.713482668340758,0.999998222324989,1,up,,Initial TCR Response,5,Phospholipase C complex,40,45,TXK,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,24,bortezomib,dmso,78,ZAP70,0.0184108089242642,0.133258043692662,0.0186926207019089,0.960229398257146,0.999998222324989,1,up,,Initial TCR Response,5,TCR Output,45,50,ZAP70,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd8_memory,24,bortezomib,dmso,163,BCL10,0.071342783571653,0.0857928250622408,0.0150288887640011,0.724180252546247,0.939355515561986,1,up,,PKCθ–IKK–NF-κβ pathway,4,CBM complex,36,40,BCL10,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,24,bortezomib,dmso,163,CARD11,-0.103852756735739,0.135025912071068,0.00741894866901582,0.312805517273786,0.755400196542637,1,up,CARMA1,PKCθ–IKK–NF-κβ pathway,4,CBM complex,34,38,CARD11 | CARMA1,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,24,bortezomib,dmso,163,CD247,-0.00816634741125229,-0.0708170257768664,-0.0339714376055291,0.955268722203696,0.996607244697118,-1,dn,CD3ζ,Initial TCR Response,5,TCR complex,56,61,CD247 | CD3ζ,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,24,bortezomib,dmso,163,CD3D,-0.0709449509847721,-0.400954685614317,-0.21365850742601,0.105239437583352,0.488945700749771,-1,dn,CD3δ,Initial TCR Response,5,TCR complex,60,65,CD3D | CD3δ,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,24,bortezomib,dmso,163,CD3E,-0.0766000026264503,-0.876173899810637,-0.222549747559173,0.00389070012412338,0.0667379928123442,-1,dn,CD3ε,Initial TCR Response,5,TCR complex,61,66,CD3E | CD3ε,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,24,bortezomib,dmso,163,CD3G,-0.0314836764052084,-0.892783965878089,-0.264512556303268,0.00164048918466452,0.03574476031113,-1,dn,CD3γ,Initial TCR Response,5,TCR complex,57,62,CD3G | CD3γ,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,24,bortezomib,dmso,163,CD8A,-0.0599373656721167,-1.05048260833278,-0.372486570014623,6.9749608033773e-05,0.0030191678226755,-1,dn,CD8ɑ,Initial TCR Response,5,TCR Coreceptor,54,59,CD8A | CD8ɑ,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,24,bortezomib,dmso,163,CD8B,-0.0330924223224662,-0.587519979858693,-0.262248616535677,0.0295827195110177,0.250094725662023,-1,dn,CD8β,Initial TCR Response,5,TCR Coreceptor,53,58,CD8B | CD8β,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,24,bortezomib,dmso,163,CHUK,-0.0522724031843571,0.520738538297636,0.0652547629967436,0.292145729559425,0.73887516172417,1,up,IKKɑ,PKCθ–IKK–NF-κβ pathway,4,IKb Kinase complex,30,34,CHUK | IKKɑ,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,24,bortezomib,dmso,163,CSK,-0.0877154334556144,-0.163541294129576,-0.0345420043141545,0.613183024332629,0.911087043865824,-1,dn,,Initial TCR Response,5,TCR Negative Regulator,48,53,CSK,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,24,bortezomib,dmso,163,DGKA,-0.0766756315683543,-0.391429164211698,-0.136830100023043,0.146352356408832,0.56739788153822,-1,dn,DGKɑ,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,19,22,DGKA | DGKɑ,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,24,bortezomib,dmso,163,FOS,0.0702636304743132,-1.16944296451179,-0.0581555503062307,0.120594704421715,0.521572484436077,-1,dn,c-Fos,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,20,23,FOS | c-Fos,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,24,bortezomib,dmso,163,FYN,-0.300321665663243,-0.208200708399051,-0.304104819260628,7.29151909741616e-05,0.00308574490394731,-1,dn,,Initial TCR Response,5,ITAM-targeting Kinase,51,56,FYN,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,24,bortezomib,dmso,163,GRAP2,-0.168149796736469,-1.20847420417614,-0.661660148285578,3.84120340055179e-07,3.41411327459303e-05,-1,dn,GADS,Initial TCR Response,5,Phospholipase C complex,42,47,GRAP2 | GADS,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,24,bortezomib,dmso,163,IKBKB,-0.0629395137652002,-0.115787280283649,-0.0469934423231546,0.60011208474122,0.908016993553178,-1,dn,IKKβ,PKCθ–IKK–NF-κβ pathway,4,IKb Kinase complex,31,35,IKBKB | IKKβ,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,24,bortezomib,dmso,163,ITK,-0.254795795099959,-0.842409218021143,-0.533024890414964,3.74595005249653e-06,0.000235115122613134,-1,dn,,Initial TCR Response,5,Phospholipase C complex,41,46,ITK,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,24,bortezomib,dmso,163,JUN,-0.0433969846773265,-0.318224640748492,-0.106475817228539,0.414544803034777,0.819055817650062,-1,dn,c-Jun,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,21,24,JUN | c-Jun,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,24,bortezomib,dmso,163,LAT,-0.0496052249938855,-0.795594958464495,-0.178572964321008,0.0176537376791584,0.185869510361329,-1,dn,,Initial TCR Response,5,Phospholipase C complex,43,48,LAT,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,24,bortezomib,dmso,163,LCK,-0.0340815964658658,-0.842628198521986,-0.273596519448951,0.00363659318325408,0.0639685234039491,-1,dn,,Initial TCR Response,5,ITAM-targeting Kinase,52,57,LCK,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,24,bortezomib,dmso,163,LCP2,-0.400697803716567,-1.35767242708748,-0.822855732058854,4.40933569617719e-14,1.73958791632514e-11,-1,dn,SLP-76,Initial TCR Response,5,Phospholipase C complex,44,49,LCP2 | SLP-76,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,24,bortezomib,dmso,163,MALT1,-0.0187802236700268,-0.00608006413938269,-0.00926444159591422,0.962325407664211,0.996683183014942,-1,dn,,PKCθ–IKK–NF-κβ pathway,4,CBM complex,33,37,MALT1,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,24,bortezomib,dmso,163,MAP2K1,0.15238335493227,0.710281654541678,0.335951921163706,0.000594183528501642,0.0165194984350205,1,up,MEK1,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,15,17,MAP2K1 | MEK1,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,24,bortezomib,dmso,163,MAP2K2,-0.0156401464955597,0.0141525287645169,0.000226168426869733,0.953997985939881,0.996210675468902,1,up,MEK2,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,14,16,MAP2K2 | MEK2,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,24,bortezomib,dmso,163,MAP2K7,0.0378641012986891,-0.0575659094239289,-0.00390700116756196,0.927783587499654,0.9894416991285,-1,dn,MKK7,p38 and JNK pathways,1,JNK activation complex,9,10,MAP2K7 | MKK7,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,24,bortezomib,dmso,163,MAP3K7,0.0911729981692604,0.334493197585387,0.133640234445329,0.191161006862041,0.631294805400844,1,up,TAK1,p38 and JNK pathways,1,JNK activation complex,10,11,MAP3K7 | TAK1,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,24,bortezomib,dmso,163,MAPK1,-0.0420972030374609,-0.0782962594548551,-0.0497234534126346,0.742068896228345,0.942767472277082,-1,dn,ERK2,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,13,15,MAPK1 | ERK2,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,24,bortezomib,dmso,163,MAPK14,0.0358255838476296,-0.0701709677408839,-0.0147481322865721,0.843324795810621,0.96919766032612,-1,dn,p38ɑ,p38 and JNK pathways,1,p38,11,12,MAPK14 | p38ɑ,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,24,bortezomib,dmso,163,MAPK8,0.0844296952394836,0.747664538882266,0.372428933068805,0.00274319508246874,0.0536375411656202,1,up,JNK1,p38 and JNK pathways,1,JNK activation complex,7,8,MAPK8 | JNK1,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,24,bortezomib,dmso,163,MAPK9,-0.0274879910135137,-0.118137810390453,-0.0179515551287487,0.900246979933631,0.981584506605912,-1,dn,JNK2,p38 and JNK pathways,1,JNK activation complex,8,9,MAPK9 | JNK2,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,24,bortezomib,dmso,163,MAPKAP1,0.0736138076006917,0.0266211111829721,0.0379990975481902,0.525486047604963,0.882141740702663,1,up,,mTORC pathways,0,mTORC2 complex,3,3,MAPKAP1,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,24,bortezomib,dmso,163,MTOR,-0.0948621599614174,-0.233243363885411,-0.081141450527186,0.270948709474323,0.716040752161381,-1,dn,,mTORC pathways,0,mTORC1 complex,5,5,MTOR,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,24,bortezomib,dmso,163,NFATC1,-0.0197291578221156,0.286894613342737,0.0245087937233581,0.780769776396488,0.953596799951368,1,up,,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,25,28,NFATC1,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,24,bortezomib,dmso,163,NFKB1,-0.0996941585809262,-0.312944175176594,-0.185739669183738,0.179680259558242,0.619676846905878,-1,dn,NF-κB,PKCθ–IKK–NF-κβ pathway,4,NFKB complex,28,32,NFKB1 | NF-κB,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,24,bortezomib,dmso,163,NFKBIA,-0.0968853051328324,0.181108123245386,0.0239111643274402,0.54227575370925,0.888247255729763,1,up,IκBɑ,PKCθ–IKK–NF-κβ pathway,4,NFKB complex,26,30,NFKBIA | IκBɑ,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,24,bortezomib,dmso,163,PAG1,-0.24354730735279,-0.534149581417689,-0.391108830527323,0.000399528690670872,0.0121694676551771,-1,dn,,Initial TCR Response,5,TCR Regulator,46,51,PAG1,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,24,bortezomib,dmso,163,PDPK1,-0.053202249642558,0.0716700302042279,0.00439847709338118,0.727934429717105,0.939355515561986,1,up,PDK1,PKCθ–IKK–NF-κβ pathway,4,CBM complex activator,35,39,PDPK1 | PDK1,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,24,bortezomib,dmso,163,PLCG1,-0.0416996836121594,-0.607367582837534,-0.115957254420386,0.120581595924057,0.521572484436077,-1,dn,PLC-γ1,Initial TCR Response,5,Phospholipase C complex,39,44,PLCG1 | PLC-γ1,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,24,bortezomib,dmso,163,PLCG2,-0.0470975005376281,0.0952684884788795,0.0200294294910295,0.74643672975349,0.943769547043726,1,up,PLC-γ2,Initial TCR Response,5,Phospholipase C complex,38,43,PLCG2 | PLC-γ2,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,24,bortezomib,dmso,163,PPP3CA,-0.0725671905325625,-0.767066484232051,-0.405018724217795,0.00262787602753982,0.0520860116941804,-1,dn,,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,24,27,PPP3CA,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,24,bortezomib,dmso,163,PPP3CB,0.0436287117204772,0.108134040253102,0.0502455208095475,0.792338233687734,0.955149944708802,1,up,,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,23,26,PPP3CB,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,24,bortezomib,dmso,163,PPP3CC,0.176343999929159,0.257798560516352,0.22133817095909,0.0168404083221281,0.179797400707257,1,up,,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,22,25,PPP3CC,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,24,bortezomib,dmso,163,PRKCQ,-0.0958761834260745,-0.390041405417906,-0.213461167501034,0.10703395943302,0.493462147880995,-1,dn,PKC-Θ,PKCθ–IKK–NF-κβ pathway,4,CBM complex activator,37,41,PRKCQ | PKC-Θ,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,24,bortezomib,dmso,163,PRR5,0.0865827744617032,0.250368810186535,0.0340631179285436,0.60219338065538,0.908529597007687,1,up,,mTORC pathways,0,mTORC2 complex,2,2,PRR5,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,24,bortezomib,dmso,163,PTPN22,-0.10155934854901,-0.692740146203508,-0.177666325394585,0.0452025675258556,0.321462036010054,-1,dn,Lyp/Pep,Initial TCR Response,5,TCR Negative Regulator,47,52,PTPN22 | Lyp/Pep,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,24,bortezomib,dmso,163,PTPRC,-0.410189245233849,-1.73583596074078,-0.510339676720688,5.67584143877769e-11,1.34355275200781e-08,-1,dn,CD45,Initial TCR Response,5,TCR Activator,49,54,PTPRC | CD45,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,24,bortezomib,dmso,163,PTPRJ,-0.0749714958322095,-0.436876764406669,-0.206681010578348,0.115516753459331,0.509763298072979,-1,dn,CD148,Initial TCR Response,5,TCR Activator,50,55,PTPRJ | CD148,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,24,bortezomib,dmso,163,RAF1,0.032620016311213,0.137879892070231,0.0652412748343728,0.721328581984382,0.939355515561986,1,up,c-RAF,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,16,18,RAF1 | c-RAF,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,24,bortezomib,dmso,163,RASGRP1,-0.143325779733848,-0.00396985518059632,-0.0795011258923614,0.130671424916942,0.539285332345616,-1,dn,,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,18,20,RASGRP1,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,24,bortezomib,dmso,163,RELA,0.0366887713935731,-0.505412976528768,-0.0291150118467273,0.580395224616087,0.902372510452289,-1,dn,p65,PKCθ–IKK–NF-κβ pathway,4,NFKB complex,27,31,RELA | p65,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,24,bortezomib,dmso,163,RICTOR,-0.0593523734049101,-0.213399007461132,-0.121795454231491,0.432394067366883,0.826172916783713,-1,dn,,mTORC pathways,0,mTORC2 complex,1,1,RICTOR,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,24,bortezomib,dmso,163,RPTOR,0.107533685239283,0.713558188297111,0.330110547948479,0.00155845234163556,0.0343398341767303,1,up,,mTORC pathways,0,mTORC1 complex,4,4,RPTOR,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,24,bortezomib,dmso,163,SOS1,-0.0776269091457139,-0.359102194439886,-0.167111239953714,0.30303451839492,0.74575679321793,-1,dn,,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,17,19,SOS1,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,24,bortezomib,dmso,163,TRAC,-0.0848335786566913,-0.454337681552894,-0.226952207227037,0.0470468856101032,0.326178616970464,-1,dn,TCRɑ,Initial TCR Response,5,TCR complex,58,63,TRAC | TCRɑ,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,24,bortezomib,dmso,163,TRAF6,0.0896484250242247,0.112446797491896,0.0333025206883689,0.567806828844941,0.900131476272828,1,up,,PKCθ–IKK–NF-κβ pathway,4,CBM complex,32,36,TRAF6,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,24,bortezomib,dmso,163,TRBC1,-0.193896389403023,-1.13035056496029,-0.324805147785129,0.00021757297897855,0.00763810224931053,-1,dn,TCRβ,Initial TCR Response,5,TCR complex,59,64,TRBC1 | TCRβ,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,24,bortezomib,dmso,163,TXK,-0.0273357092349188,-0.654220224462619,-0.30012487421478,0.0179083473814177,0.187810959563349,-1,dn,,Initial TCR Response,5,Phospholipase C complex,40,45,TXK,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,24,bortezomib,dmso,163,ZAP70,-0.122466945652318,-0.716323725104407,-0.142476251423845,0.0203239632279596,0.206163650500956,-1,dn,,Initial TCR Response,5,TCR Output,45,50,ZAP70,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_naive,24,bortezomib,dmso,451,BCL10,0.0545128023078619,-0.60195090889016,-0.046403518762638,0.061962860638409,0.28279612256966,-1,dn,,PKCθ–IKK–NF-κβ pathway,4,CBM complex,36,40,BCL10,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,24,bortezomib,dmso,451,CARD11,-0.0189000734161245,0.0772317057719081,0.0220495026481211,0.767944573620341,0.910885866259815,1,up,CARMA1,PKCθ–IKK–NF-κβ pathway,4,CBM complex,34,38,CARD11 | CARMA1,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,24,bortezomib,dmso,451,CD247,0.0787511623742582,0.144715533591781,0.107239328768259,0.09046739011277,0.345266620663794,1,up,CD3ζ,Initial TCR Response,5,TCR complex,56,61,CD247 | CD3ζ,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,24,bortezomib,dmso,451,CD3D,0.00489450483407378,-0.288849441131041,-0.109854395323157,0.115189208992787,0.389522633329623,-1,dn,CD3δ,Initial TCR Response,5,TCR complex,60,65,CD3D | CD3δ,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,24,bortezomib,dmso,451,CD3E,-0.0667176519862654,-0.706370318705134,-0.23535327204141,1.6039802121558e-06,6.27962018270761e-05,-1,dn,CD3ε,Initial TCR Response,5,TCR complex,61,66,CD3E | CD3ε,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,24,bortezomib,dmso,451,CD3G,-0.106949755043319,-0.805822158596617,-0.317224420947535,5.48606184439562e-10,4.39887208850145e-08,-1,dn,CD3γ,Initial TCR Response,5,TCR complex,57,62,CD3G | CD3γ,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,24,bortezomib,dmso,451,CD8A,-0.0942309879806022,-0.639644628597065,-0.269165654741698,8.4046319532602e-07,3.46961514149687e-05,-1,dn,CD8ɑ,Initial TCR Response,5,TCR Coreceptor,54,59,CD8A | CD8ɑ,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,24,bortezomib,dmso,451,CD8B,-0.174138481388778,-0.77081246395016,-0.396721752782267,8.48524338462036e-12,9.31032165583542e-10,-1,dn,CD8β,Initial TCR Response,5,TCR Coreceptor,53,58,CD8B | CD8β,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,24,bortezomib,dmso,451,CHUK,-0.0302327050560959,0.511110077110099,0.0675883112383263,0.0491499449141031,0.249307415230357,1,up,IKKɑ,PKCθ–IKK–NF-κβ pathway,4,IKb Kinase complex,30,34,CHUK | IKKɑ,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,24,bortezomib,dmso,451,CSK,0.0328000242127273,-0.13619175290447,-0.020158145938507,0.4411159635527,0.726795962405479,-1,dn,,Initial TCR Response,5,TCR Negative Regulator,48,53,CSK,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,24,bortezomib,dmso,451,DGKA,-0.0361332018975993,0.0172347153620967,-0.0101128972110548,0.53694761770934,0.788588619950367,-1,dn,DGKɑ,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,19,22,DGKA | DGKɑ,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,24,bortezomib,dmso,451,FOS,0.0119192816799912,-0.587969941278548,-0.029570368604489,0.220674440882314,0.537914107722191,-1,dn,c-Fos,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,20,23,FOS | c-Fos,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,24,bortezomib,dmso,451,FYN,-0.0441186592545245,-0.143897727418888,-0.0865219201665939,0.33191693202276,0.640965894164053,-1,dn,,Initial TCR Response,5,ITAM-targeting Kinase,51,56,FYN,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,24,bortezomib,dmso,451,GRAP2,-0.139678059854559,-0.298604272618397,-0.216199504747753,0.00035626378132285,0.00656489647993834,-1,dn,GADS,Initial TCR Response,5,Phospholipase C complex,42,47,GRAP2 | GADS,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,24,bortezomib,dmso,451,IKBKB,0.0109340372278629,-0.0256370901676917,-0.00432539873849169,0.946053024802752,0.97867325011588,-1,dn,IKKβ,PKCθ–IKK–NF-κβ pathway,4,IKb Kinase complex,31,35,IKBKB | IKKβ,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,24,bortezomib,dmso,451,ITK,-0.137991348639494,-0.769276341085357,-0.399571729646741,1.86287127553576e-09,1.38700746131185e-07,-1,dn,,Initial TCR Response,5,Phospholipase C complex,41,46,ITK,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,24,bortezomib,dmso,451,JUN,0.0242287795253177,-0.0218709173342836,-0.000489534787721596,0.908208640296646,0.964169554606459,-1,dn,c-Jun,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,21,24,JUN | c-Jun,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,24,bortezomib,dmso,451,LAT,-0.0317803044362185,-0.501947280531254,-0.124420730900428,0.00578178340904166,0.0592313167665828,-1,dn,,Initial TCR Response,5,Phospholipase C complex,43,48,LAT,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,24,bortezomib,dmso,451,LCK,-0.0397207278475362,-0.811609926819295,-0.301451660399076,4.60649734477798e-08,2.63106721630846e-06,-1,dn,,Initial TCR Response,5,ITAM-targeting Kinase,52,57,LCK,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,24,bortezomib,dmso,451,LCP2,-0.0820308407496641,-0.821857660878994,-0.376272231490604,1.01977542156138e-09,7.87398818555584e-08,-1,dn,SLP-76,Initial TCR Response,5,Phospholipase C complex,44,49,LCP2 | SLP-76,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,24,bortezomib,dmso,451,MALT1,0.0217072790458171,-0.195933409541139,-0.0625524168419143,0.333236349755671,0.641324237390385,-1,dn,,PKCθ–IKK–NF-κβ pathway,4,CBM complex,33,37,MALT1,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,24,bortezomib,dmso,451,MAP2K1,0.0534345772944333,0.355606637916347,0.130578455539719,0.0259878382788487,0.167567431540744,1,up,MEK1,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,15,17,MAP2K1 | MEK1,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,24,bortezomib,dmso,451,MAP2K2,0.0904156014919383,0.426367963857072,0.0580390540475714,0.0183900857135815,0.133120594414545,1,up,MEK2,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,14,16,MAP2K2 | MEK2,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,24,bortezomib,dmso,451,MAP2K7,0.0138420379104309,-0.168979870841571,-0.017840839838013,0.724454371135323,0.888023666161614,-1,dn,MKK7,p38 and JNK pathways,1,JNK activation complex,9,10,MAP2K7 | MKK7,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,24,bortezomib,dmso,451,MAP3K7,-0.0533129436624571,-0.103946875618382,-0.0569411770694637,0.276035135581897,0.590037071519829,-1,dn,TAK1,p38 and JNK pathways,1,JNK activation complex,10,11,MAP3K7 | TAK1,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,24,bortezomib,dmso,451,MAPK1,0.0358299289120204,-0.0897896815848307,-0.0193207219788666,0.515198177468844,0.774934632379635,-1,dn,ERK2,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,13,15,MAPK1 | ERK2,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,24,bortezomib,dmso,451,MAPK14,0.091205848606024,-0.211432604214432,-0.0468166349238675,0.0238519718609552,0.157983791380862,-1,dn,p38ɑ,p38 and JNK pathways,1,p38,11,12,MAPK14 | p38ɑ,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,24,bortezomib,dmso,451,MAPK8,0.0351932660221662,0.321789613886833,0.164543870161388,0.0426659451202635,0.226143784468017,1,up,JNK1,p38 and JNK pathways,1,JNK activation complex,7,8,MAPK8 | JNK1,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,24,bortezomib,dmso,451,MAPK9,0.180793645176679,0.122200894167225,0.0451712535512704,0.00381201707839996,0.0432495379820099,1,up,JNK2,p38 and JNK pathways,1,JNK activation complex,8,9,MAPK9 | JNK2,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,24,bortezomib,dmso,451,MAPKAP1,0.0144045208983739,0.219404285444163,0.0925390023332814,0.269989244866826,0.585093636420079,1,up,,mTORC pathways,0,mTORC2 complex,3,3,MAPKAP1,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,24,bortezomib,dmso,451,MTOR,0.00537630036725618,0.165492348726266,0.0415655596905244,0.596249357629072,0.822191742926352,1,up,,mTORC pathways,0,mTORC1 complex,5,5,MTOR,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,24,bortezomib,dmso,451,NFATC1,-0.00278322452934894,-0.166138840740386,-0.0193606851957952,0.769205681501653,0.910885866259815,-1,dn,,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,25,28,NFATC1,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,24,bortezomib,dmso,451,NFKB1,-0.0250874731001699,0.0306051254528478,-0.00188130069960923,0.804059398281738,0.923306433802178,-1,dn,NF-κB,PKCθ–IKK–NF-κβ pathway,4,NFKB complex,28,32,NFKB1 | NF-κB,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,24,bortezomib,dmso,451,NFKBIA,0.0384544388289556,-0.062097261279608,-0.00371608987881586,0.614736715182995,0.832865876183753,-1,dn,IκBɑ,PKCθ–IKK–NF-κβ pathway,4,NFKB complex,26,30,NFKBIA | IκBɑ,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,24,bortezomib,dmso,451,PAG1,-0.0458922327403673,-0.641918059798197,-0.285155620845443,2.46355141021997e-05,0.000682510139861273,-1,dn,,Initial TCR Response,5,TCR Regulator,46,51,PAG1,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,24,bortezomib,dmso,451,PDPK1,0.020971768915957,0.217906062598874,0.032085407762063,0.517457694608031,0.776931889689659,1,up,PDK1,PKCθ–IKK–NF-κβ pathway,4,CBM complex activator,35,39,PDPK1 | PDK1,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,24,bortezomib,dmso,451,PLCG1,0.0217338343844132,-0.29458994335718,-0.0686397129024182,0.157843796024739,0.457034519114686,-1,dn,PLC-γ1,Initial TCR Response,5,Phospholipase C complex,39,44,PLCG1 | PLC-γ1,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,24,bortezomib,dmso,451,PLCG2,-0.0202354495565997,-0.0437672907411088,-0.0282030108410328,0.863833091851282,0.947848928476766,-1,dn,PLC-γ2,Initial TCR Response,5,Phospholipase C complex,38,43,PLCG2 | PLC-γ2,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,24,bortezomib,dmso,451,PPP3CA,-0.0691354730028284,-0.384712997121519,-0.21243381027479,0.00646771529932259,0.0639031728448473,-1,dn,,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,24,27,PPP3CA,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,24,bortezomib,dmso,451,PPP3CB,-0.00603477009827453,-0.163687447225916,-0.0541145831249649,0.53866434384241,0.789580236122667,-1,dn,,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,23,26,PPP3CB,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,24,bortezomib,dmso,451,PPP3CC,0.101295009646482,0.102587093520585,0.0900979147208167,0.0364424393934459,0.207153034834318,1,up,,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,22,25,PPP3CC,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,24,bortezomib,dmso,451,PRKCQ,0.0335224869664392,0.0522151327869191,0.0435039967753275,0.653357462947577,0.855006347900777,1,up,PKC-Θ,PKCθ–IKK–NF-κβ pathway,4,CBM complex activator,37,41,PRKCQ | PKC-Θ,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,24,bortezomib,dmso,451,PRR5,-0.0210289977674736,0.530646536797224,0.0497123338941256,0.102340061602881,0.366885787249998,1,up,,mTORC pathways,0,mTORC2 complex,2,2,PRR5,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,24,bortezomib,dmso,451,PTPN22,0.0883281724073968,-1.14577098248383,-0.171955765671823,7.49838368631827e-08,4.06032607533818e-06,-1,dn,Lyp/Pep,Initial TCR Response,5,TCR Negative Regulator,47,52,PTPN22 | Lyp/Pep,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,24,bortezomib,dmso,451,PTPRC,-0.156097440186714,-2.21157066723588,-0.208752186582033,4.05631584712243e-07,1.80885656947347e-05,-1,dn,CD45,Initial TCR Response,5,TCR Activator,49,54,PTPRC | CD45,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,24,bortezomib,dmso,451,PTPRJ,-0.0350560656424807,-0.177825886072139,-0.0640553813275722,0.40292387736664,0.695504494589196,-1,dn,CD148,Initial TCR Response,5,TCR Activator,50,55,PTPRJ | CD148,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,24,bortezomib,dmso,451,RAF1,0.0272681833193056,0.173900787195556,0.0721137322815284,0.377660579111519,0.677870195942968,1,up,c-RAF,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,16,18,RAF1 | c-RAF,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,24,bortezomib,dmso,451,RASGRP1,0.0485344536659877,0.0307797004193719,0.0390316740581687,0.424167707090708,0.712557314550648,1,up,,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,18,20,RASGRP1,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,24,bortezomib,dmso,451,RICTOR,0.0585378177991208,0.0975631178701902,0.0768185071562404,0.213167553824805,0.530280212240119,1,up,,mTORC pathways,0,mTORC2 complex,1,1,RICTOR,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,24,bortezomib,dmso,451,RPTOR,0.0785009911428185,0.440587367086583,0.204246565350572,0.000503043353988177,0.0088499547023363,1,up,,mTORC pathways,0,mTORC1 complex,4,4,RPTOR,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,24,bortezomib,dmso,451,SOS1,-0.169699714110472,-0.128281310647278,-0.177899600608923,0.000133975014934748,0.00285004502433894,-1,dn,,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,17,19,SOS1,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,24,bortezomib,dmso,451,TRAC,-0.044077702193822,-0.242135425042317,-0.120240568567245,0.0929827535177739,0.350218239198155,-1,dn,TCRɑ,Initial TCR Response,5,TCR complex,58,63,TRAC | TCRɑ,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,24,bortezomib,dmso,451,TRAF6,0.00963938400473341,0.330929675866395,0.052296701799359,0.253330810715905,0.570528891961782,1,up,,PKCθ–IKK–NF-κβ pathway,4,CBM complex,32,36,TRAF6,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,24,bortezomib,dmso,451,TRBC1,-0.188587026284171,-0.243916849695701,-0.125357095777029,0.00224849486504861,0.0288464595071391,-1,dn,TCRβ,Initial TCR Response,5,TCR complex,59,64,TRBC1 | TCRβ,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,24,bortezomib,dmso,451,TXK,-0.201939751132552,-0.527713429012155,-0.296438337835111,2.85567613357835e-07,1.36859099298332e-05,-1,dn,,Initial TCR Response,5,Phospholipase C complex,40,45,TXK,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,24,bortezomib,dmso,451,ZAP70,0.0143493432104645,-0.0435164633617383,-0.00607632459836166,0.883199251707745,0.956493319479336,-1,dn,,Initial TCR Response,5,TCR Output,45,50,ZAP70,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd4_cm,72,bortezomib,dmso,648,BCL10,0.0416370242590424,-0.0195560196850917,0.00219176767317969,0.492557780089114,0.542366325969973,1,up,,PKCθ–IKK–NF-κβ pathway,4,CBM complex,36,40,BCL10,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,72,bortezomib,dmso,648,CARD11,0.107034247232371,0.272763108197089,0.174068882877566,0.000916340937502796,0.00290939841848052,1,up,CARMA1,PKCθ–IKK–NF-κβ pathway,4,CBM complex,34,38,CARD11 | CARMA1,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,72,bortezomib,dmso,648,CD247,0.0524106103319446,0.116973860634458,0.073232457196309,0.252185321261117,0.308429306595321,1,up,CD3ζ,Initial TCR Response,5,TCR complex,56,61,CD247 | CD3ζ,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,72,bortezomib,dmso,648,CD3D,0.0716319625036688,-0.124170223547304,0.0115223047177293,0.0356218238267299,0.0624854176122472,1,up,CD3δ,Initial TCR Response,5,TCR complex,60,65,CD3D | CD3δ,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,72,bortezomib,dmso,648,CD3E,0.0128162247598679,-0.838807281876543,-0.237288553049213,3.75059398027692e-10,3.46048231243953e-09,-1,dn,CD3ε,Initial TCR Response,5,TCR complex,61,66,CD3E | CD3ε,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,72,bortezomib,dmso,648,CD3G,-0.0662252136510295,-1.11700357886391,-0.370672899935461,7.17415087454487e-19,1.31984126472222e-17,-1,dn,CD3γ,Initial TCR Response,5,TCR complex,57,62,CD3G | CD3γ,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,72,bortezomib,dmso,648,CD4,0.0223444285981041,-0.552436139811788,-0.158836735375164,4.51299655432805e-05,0.000198750451535924,-1,dn,,Initial TCR Response,5,TCR Coreceptor,55,60,CD4,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,72,bortezomib,dmso,648,CHUK,0.0656782294128874,0.171012448225732,0.0356646762541107,0.0394877020778183,0.0677685314011834,1,up,IKKɑ,PKCθ–IKK–NF-κβ pathway,4,IKb Kinase complex,30,34,CHUK | IKKɑ,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,72,bortezomib,dmso,648,CSK,0.0230475644203041,-0.481860937911403,-0.0769957983122816,0.00823589723981444,0.0186760840738834,-1,dn,,Initial TCR Response,5,TCR Negative Regulator,48,53,CSK,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,72,bortezomib,dmso,648,DGKA,0.0312290159866667,-0.307734124423863,-0.0895155673708619,0.0235274321409795,0.0445226400333168,-1,dn,DGKɑ,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,19,22,DGKA | DGKɑ,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,72,bortezomib,dmso,648,FYN,-0.0524491229340609,-0.510358093209712,-0.160882613492658,0.00409581802695205,0.0104631409563095,-1,dn,,Initial TCR Response,5,ITAM-targeting Kinase,51,56,FYN,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,72,bortezomib,dmso,648,GRAP2,-0.155997329876914,-1.57543815595895,-0.692897945545805,3.22946814833571e-37,1.35178425933777e-35,-1,dn,GADS,Initial TCR Response,5,Phospholipase C complex,42,47,GRAP2 | GADS,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,72,bortezomib,dmso,648,IKBKB,0.0542306428072981,-0.523737482168556,-0.126083894549998,0.000113967208531196,0.000459545195690307,-1,dn,IKKβ,PKCθ–IKK–NF-κβ pathway,4,IKb Kinase complex,31,35,IKBKB | IKKβ,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,72,bortezomib,dmso,648,IKBKG,0.0639394666443783,0.596397032835808,0.0399053804519094,0.00769755882289606,0.0177016694200924,1,up,IKKγ,PKCθ–IKK–NF-κβ pathway,4,IKb Kinase complex,29,33,IKBKG | IKKγ,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,72,bortezomib,dmso,648,ITK,-0.305996495994322,-2.05027644279509,-0.899698837498494,1.15708645457702e-64,1.30350788864386e-62,-1,dn,,Initial TCR Response,5,Phospholipase C complex,41,46,ITK,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,72,bortezomib,dmso,648,JUN,0.104191688691768,0.583624651198307,0.138983444822531,4.25149669968148e-05,0.000188324793129095,1,up,c-Jun,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,21,24,JUN | c-Jun,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,72,bortezomib,dmso,648,LAT,0.0261283047146058,-1.28548005856654,-0.248578646316873,1.98744476582207e-16,3.06341781894027e-15,-1,dn,,Initial TCR Response,5,Phospholipase C complex,43,48,LAT,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,72,bortezomib,dmso,648,LCK,-0.0888580265241233,-1.05066499917084,-0.370685834460028,1.64185210464808e-17,2.73392344067769e-16,-1,dn,,Initial TCR Response,5,ITAM-targeting Kinase,52,57,LCK,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,72,bortezomib,dmso,648,LCP2,-0.245370307140437,-1.50930042181832,-0.669366609476574,9.2227516005635e-43,5.36035722007274e-41,-1,dn,SLP-76,Initial TCR Response,5,Phospholipase C complex,44,49,LCP2 | SLP-76,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,72,bortezomib,dmso,648,MALT1,-0.144826074228035,-0.891061813076135,-0.419677182081836,1.06062074751862e-15,1.53621655890594e-14,-1,dn,,PKCθ–IKK–NF-κβ pathway,4,CBM complex,33,37,MALT1,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,72,bortezomib,dmso,648,MAP2K1,0.0433911408385822,0.0381590208840928,0.0324027429657878,0.473078474098681,0.52458878067207,1,up,MEK1,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,15,17,MAP2K1 | MEK1,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,72,bortezomib,dmso,648,MAP2K2,0.0665756556784434,0.482740637130947,0.0869447084727224,0.00071020961847219,0.0023295224801236,1,up,MEK2,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,14,16,MAP2K2 | MEK2,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,72,bortezomib,dmso,648,MAP2K7,0.0367644885422558,0.447460270639994,0.0518619207343238,0.047620575602245,0.0789494462882423,1,up,MKK7,p38 and JNK pathways,1,JNK activation complex,9,10,MAP2K7 | MKK7,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,72,bortezomib,dmso,648,MAP3K7,0.0979626149950484,0.354637550950211,0.156869394098284,0.0002142914894144,0.000810107793543023,1,up,TAK1,p38 and JNK pathways,1,JNK activation complex,10,11,MAP3K7 | TAK1,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,72,bortezomib,dmso,648,MAPK1,0.046669012140089,-0.318091585349492,-0.0927089828043066,0.0116450498155621,0.0249439153913156,-1,dn,ERK2,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,13,15,MAPK1 | ERK2,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,72,bortezomib,dmso,648,MAPK14,0.0550227418396535,0.0729541356987207,0.0504248017520496,0.189648877217075,0.243567347587025,1,up,p38ɑ,p38 and JNK pathways,1,p38,11,12,MAPK14 | p38ɑ,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,72,bortezomib,dmso,648,MAPK8,0.133476023874469,1.05198346349674,0.492569854041991,2.63737641918985e-19,4.99295846993929e-18,1,up,JNK1,p38 and JNK pathways,1,JNK activation complex,7,8,MAPK8 | JNK1,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,72,bortezomib,dmso,648,MAPK9,0.152634917470582,0.0793290359832406,0.0366602416104494,0.000183442772768105,0.000706293376164119,1,up,JNK2,p38 and JNK pathways,1,JNK activation complex,8,9,MAPK9 | JNK2,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,72,bortezomib,dmso,648,MAPKAP1,0.0814150128961531,0.0494956561017629,0.0583668138455347,0.0457575230845027,0.0762746167634346,1,up,,mTORC pathways,0,mTORC2 complex,3,3,MAPKAP1,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,72,bortezomib,dmso,648,MTOR,0.0389972060745584,0.202840091832247,0.0632394781347151,0.137653219909953,0.188375169717804,1,up,,mTORC pathways,0,mTORC1 complex,5,5,MTOR,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,72,bortezomib,dmso,648,NFATC1,0.11429150801319,0.325213050861851,0.0777465210792229,0.00161946427868705,0.0047652136275926,1,up,,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,25,28,NFATC1,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,72,bortezomib,dmso,648,NFKB1,-0.131780801654371,-0.419228440266011,-0.240949931435911,1.29365773564667e-06,7.59628496639373e-06,-1,dn,NF-κB,PKCθ–IKK–NF-κβ pathway,4,NFKB complex,28,32,NFKB1 | NF-κB,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,72,bortezomib,dmso,648,NFKBIA,-0.0148704757561825,0.129263953214085,0.0286472950204373,0.589995902812096,0.632187953635554,1,up,IκBɑ,PKCθ–IKK–NF-κβ pathway,4,NFKB complex,26,30,NFKBIA | IκBɑ,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,72,bortezomib,dmso,648,PAG1,-0.106531666163299,-0.622788520117219,-0.277674905438916,1.34167645341564e-06,7.85802159012692e-06,-1,dn,,Initial TCR Response,5,TCR Regulator,46,51,PAG1,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,72,bortezomib,dmso,648,PDPK1,0.0706534599297923,0.183879851162962,0.0505424592601325,0.0149113503641166,0.0306386111399603,1,up,PDK1,PKCθ–IKK–NF-κβ pathway,4,CBM complex activator,35,39,PDPK1 | PDK1,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,72,bortezomib,dmso,648,PLCG1,0.032412590117025,-0.238477614496302,-0.034411271429155,0.190260475472214,0.244215338118435,-1,dn,PLC-γ1,Initial TCR Response,5,Phospholipase C complex,39,44,PLCG1 | PLC-γ1,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,72,bortezomib,dmso,648,PLCG2,-0.210553453629198,-1.11039617149836,-0.480472394741288,9.81783574709892e-25,2.44108313875416e-23,-1,dn,PLC-γ2,Initial TCR Response,5,Phospholipase C complex,38,43,PLCG2 | PLC-γ2,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,72,bortezomib,dmso,648,PPP3CA,-0.0779797452682757,-0.42724682361422,-0.223023176540252,0.00041702732664887,0.00146488920400114,-1,dn,,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,24,27,PPP3CA,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,72,bortezomib,dmso,648,PPP3CB,0.00470230346606913,-0.695291288163031,-0.218191639091829,2.66815407026712e-07,1.75283699720572e-06,-1,dn,,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,23,26,PPP3CB,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,72,bortezomib,dmso,648,PPP3CC,0.128018156053405,0.241827326831185,0.172938695878012,6.41104500659218e-05,0.000273240474942333,1,up,,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,22,25,PPP3CC,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,72,bortezomib,dmso,648,PRKCQ,-0.0280950184339802,-0.520178063142861,-0.187965426085622,0.000598527907112077,0.0020013071280314,-1,dn,PKC-Θ,PKCθ–IKK–NF-κβ pathway,4,CBM complex activator,37,41,PRKCQ | PKC-Θ,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,72,bortezomib,dmso,648,PTPN22,-0.116876275981324,-1.49255801194131,-0.503085536149893,5.58598111818077e-29,1.72202965214187e-27,-1,dn,Lyp/Pep,Initial TCR Response,5,TCR Negative Regulator,47,52,PTPN22 | Lyp/Pep,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,72,bortezomib,dmso,648,PTPRC,-0.734010975017246,-2.97794762534508,-0.985119338736063,3.14693797264946e-105,1.02556460715808e-102,-1,dn,CD45,Initial TCR Response,5,TCR Activator,49,54,PTPRC | CD45,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,72,bortezomib,dmso,648,PTPRJ,-0.0413927089646659,-0.572560688133226,-0.202796837642433,1.95479726198254e-05,9.2903776122868e-05,-1,dn,CD148,Initial TCR Response,5,TCR Activator,50,55,PTPRJ | CD148,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,72,bortezomib,dmso,648,RAF1,0.0857859248081658,0.250049159257637,0.125409586910533,0.00325481855276187,0.00863378467847443,1,up,c-RAF,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,16,18,RAF1 | c-RAF,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,72,bortezomib,dmso,648,RASGRP1,0.00334471327219588,-0.327493756395917,-0.11802346891479,0.0311657829200832,0.0560259592485735,-1,dn,,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,18,20,RASGRP1,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,72,bortezomib,dmso,648,RELA,0.0686033496704972,0.732047763178707,0.0535961802557817,0.00535866625013628,0.0130988024464221,1,up,p65,PKCθ–IKK–NF-κβ pathway,4,NFKB complex,27,31,RELA | p65,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,72,bortezomib,dmso,648,RICTOR,0.174070369748878,0.073120291410801,0.15911739086935,3.29139556932648e-07,2.1332195498567e-06,1,up,,mTORC pathways,0,mTORC2 complex,1,1,RICTOR,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,72,bortezomib,dmso,648,RPTOR,0.23682479927896,0.706480187606044,0.372974667332609,6.67476674544048e-19,1.23544110653437e-17,1,up,,mTORC pathways,0,mTORC1 complex,4,4,RPTOR,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,72,bortezomib,dmso,648,SOS1,-0.712294534096081,-0.330643901248935,-0.714856728480735,3.27386654593566e-71,4.45881078084521e-69,-1,dn,,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,17,19,SOS1,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,72,bortezomib,dmso,648,TRAC,-0.0853525082367019,-0.803170931081536,-0.33291783769016,6.70678136883149e-12,7.50912637921318e-11,-1,dn,TCRɑ,Initial TCR Response,5,TCR complex,58,63,TRAC | TCRɑ,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,72,bortezomib,dmso,648,TRAF6,0.0798934268273797,0.440770536562022,0.10609854991349,0.000710281672842945,0.0023295224801236,1,up,,PKCθ–IKK–NF-κβ pathway,4,CBM complex,32,36,TRAF6,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,72,bortezomib,dmso,648,TRBC1,-0.205739246649198,-0.849811683874858,-0.253921741852476,1.58270136562908e-11,1.67348203492067e-10,-1,dn,TCRβ,Initial TCR Response,5,TCR complex,59,64,TRBC1 | TCRβ,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,72,bortezomib,dmso,648,TXK,-0.037741420601176,-0.785383043014835,-0.32962491237656,5.53533937510156e-10,4.98617688033581e-09,-1,dn,,Initial TCR Response,5,Phospholipase C complex,40,45,TXK,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_cm,72,bortezomib,dmso,648,ZAP70,0.055694208430598,-0.842318500379254,-0.153883916166974,2.4466974200719e-08,1.84971946629297e-07,-1,dn,,Initial TCR Response,5,TCR Output,45,50,ZAP70,Bor/DMSO,CD4 CM,#00AEEF,2,6
t_cd4_em,72,bortezomib,dmso,180,BCL10,0.00509235460016462,-0.504046864729741,-0.0539537850117783,0.373691403536769,0.499707425876338,-1,dn,,PKCθ–IKK–NF-κβ pathway,4,CBM complex,36,40,BCL10,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,72,bortezomib,dmso,180,CARD11,-0.0154829986701719,-0.337656579326759,-0.138261534855219,0.304074482966737,0.435768713265712,-1,dn,CARMA1,PKCθ–IKK–NF-κβ pathway,4,CBM complex,34,38,CARD11 | CARMA1,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,72,bortezomib,dmso,180,CD247,0.143090643007801,0.122972373636428,0.151343004083096,0.0587141497612931,0.143601883901289,1,up,CD3ζ,Initial TCR Response,5,TCR complex,56,61,CD247 | CD3ζ,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,72,bortezomib,dmso,180,CD3D,-0.0793688789515788,-0.431049789158698,-0.217895229218706,0.0628231760892719,0.15109286024801,-1,dn,CD3δ,Initial TCR Response,5,TCR complex,60,65,CD3D | CD3δ,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,72,bortezomib,dmso,180,CD3E,-0.135575496191331,-1.41118223878402,-0.417280987642143,1.94314642661401e-09,4.32809281191588e-08,-1,dn,CD3ε,Initial TCR Response,5,TCR complex,61,66,CD3E | CD3ε,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,72,bortezomib,dmso,180,CD3G,-0.0864703050064505,-1.44702127051219,-0.421418500569454,9.3874124582328e-09,1.86788647002259e-07,-1,dn,CD3γ,Initial TCR Response,5,TCR complex,57,62,CD3G | CD3γ,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,72,bortezomib,dmso,180,CD4,0.0537702518408177,-0.603762760288709,-0.150301854345459,0.0276051386283655,0.0829729477268831,-1,dn,,Initial TCR Response,5,TCR Coreceptor,55,60,CD4,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,72,bortezomib,dmso,180,CHUK,0.105412742631549,-0.0164968662544798,0.0146458840611895,0.203758660602886,0.334455553994178,1,up,IKKɑ,PKCθ–IKK–NF-κβ pathway,4,IKb Kinase complex,30,34,CHUK | IKKɑ,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,72,bortezomib,dmso,180,CSK,0.0138851358509334,-0.0652829922100069,-0.0114046728139231,0.939031771263406,0.953558907589938,-1,dn,,Initial TCR Response,5,TCR Negative Regulator,48,53,CSK,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,72,bortezomib,dmso,180,DGKA,0.0587943032967135,-1.08485659071407,-0.302580409270189,1.27189589861971e-05,0.000133983010308716,-1,dn,DGKɑ,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,19,22,DGKA | DGKɑ,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,72,bortezomib,dmso,180,FOS,0.0931698019063057,-2.40727870183853,-0.0718785158949129,0.000858917057076037,0.00531863300764788,-1,dn,c-Fos,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,20,23,FOS | c-Fos,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,72,bortezomib,dmso,180,FYN,-0.015347247452306,-1.00730031590782,-0.199128839987586,0.00990371679943577,0.0381574355516988,-1,dn,,Initial TCR Response,5,ITAM-targeting Kinase,51,56,FYN,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,72,bortezomib,dmso,180,GRAP2,-0.411953533609866,-2.02106335311246,-0.995304335491773,1.06916503295722e-24,1.15341008495168e-22,-1,dn,GADS,Initial TCR Response,5,Phospholipase C complex,42,47,GRAP2 | GADS,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,72,bortezomib,dmso,180,IKBKB,0.0554326218063915,-0.0907454510657953,-0.00974403442159938,0.626442734396936,0.715394733814963,-1,dn,IKKβ,PKCθ–IKK–NF-κβ pathway,4,IKb Kinase complex,31,35,IKBKB | IKKβ,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,72,bortezomib,dmso,180,IKBKG,0.0808629795183475,0.648129407123218,0.0511917913902516,0.172983885383731,0.299477515414913,1,up,IKKγ,PKCθ–IKK–NF-κβ pathway,4,IKb Kinase complex,29,33,IKBKG | IKKγ,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,72,bortezomib,dmso,180,ITK,-0.409981849683935,-2.2031256245211,-1.04046793929727,1.6809137199401e-27,2.38903197592757e-25,-1,dn,,Initial TCR Response,5,Phospholipase C complex,41,46,ITK,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,72,bortezomib,dmso,180,JUN,0.0475274835555936,0.369758855412186,0.0888050720957525,0.35124886294864,0.479652633649859,1,up,c-Jun,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,21,24,JUN | c-Jun,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,72,bortezomib,dmso,180,LAT,0.0467823728967664,-2.09037830283425,-0.371900335259429,1.10003890712594e-11,3.17733818529214e-10,-1,dn,,Initial TCR Response,5,Phospholipase C complex,43,48,LAT,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,72,bortezomib,dmso,180,LCK,-0.195575372125954,-1.87431731932225,-0.583911714844535,1.84667709653596e-14,7.51597578290137e-13,-1,dn,,Initial TCR Response,5,ITAM-targeting Kinase,52,57,LCK,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,72,bortezomib,dmso,180,LCP2,-0.347584049276643,-2.00761046981784,-0.91254914714035,8.80057234413342e-23,7.95962876458289e-21,-1,dn,SLP-76,Initial TCR Response,5,Phospholipase C complex,44,49,LCP2 | SLP-76,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,72,bortezomib,dmso,180,MALT1,-0.127487074412038,-0.110447694556219,-0.120834481100905,0.0717121369869939,0.164982136326193,-1,dn,,PKCθ–IKK–NF-κβ pathway,4,CBM complex,33,37,MALT1,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,72,bortezomib,dmso,180,MAP2K1,0.138778852602101,0.494746771993001,0.25501136961567,0.00483756523065101,0.021843448852874,1,up,MEK1,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,15,17,MAP2K1 | MEK1,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,72,bortezomib,dmso,180,MAP2K2,0.0493836608212193,0.534081931150127,0.108235209532565,0.0983603354609212,0.204948100942645,1,up,MEK2,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,14,16,MAP2K2 | MEK2,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,72,bortezomib,dmso,180,MAP2K7,0.0198008764081346,-0.572843062327636,-0.0435513243013499,0.354746973503461,0.483029866294099,-1,dn,MKK7,p38 and JNK pathways,1,JNK activation complex,9,10,MAP2K7 | MKK7,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,72,bortezomib,dmso,180,MAP3K7,0.173965888851698,0.71058302367498,0.305968910566154,3.24276745939829e-05,0.000304997267137104,1,up,TAK1,p38 and JNK pathways,1,JNK activation complex,10,11,MAP3K7 | TAK1,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,72,bortezomib,dmso,180,MAPK1,0.107035420312556,0.0580235826241888,0.0659972299969183,0.171859874209899,0.298454870767152,1,up,ERK2,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,13,15,MAPK1 | ERK2,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,72,bortezomib,dmso,180,MAPK14,0.00852039739236691,-0.240969316592387,-0.0803320243180127,0.53393487637117,0.637155509139454,-1,dn,p38ɑ,p38 and JNK pathways,1,p38,11,12,MAPK14 | p38ɑ,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,72,bortezomib,dmso,180,MAPK8,0.31643382701217,0.923794056634677,0.530752417326085,5.52459246408155e-08,9.51292325449734e-07,1,up,JNK1,p38 and JNK pathways,1,JNK activation complex,7,8,MAPK8 | JNK1,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,72,bortezomib,dmso,180,MAPK9,0.190326168154707,1.0912637830729,0.18036488024076,0.000441630870434837,0.00305356201843516,1,up,JNK2,p38 and JNK pathways,1,JNK activation complex,8,9,MAPK9 | JNK2,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,72,bortezomib,dmso,180,MAPKAP1,0.152555685411346,0.26199217118282,0.174813093245107,0.0207188292993765,0.0666779230090173,1,up,,mTORC pathways,0,mTORC2 complex,3,3,MAPKAP1,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,72,bortezomib,dmso,180,MTOR,0.0766229678507186,0.2977271956612,0.0985789596116721,0.208980730064714,0.339973375181587,1,up,,mTORC pathways,0,mTORC1 complex,5,5,MTOR,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,72,bortezomib,dmso,180,NFATC1,0.129184227112343,0.103831516764282,0.0393736428285466,0.307320766021777,0.438834664524809,1,up,,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,25,28,NFATC1,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,72,bortezomib,dmso,180,NFKB1,-0.103729453427642,-0.848727960784156,-0.379802044043106,0.000224658029375906,0.00168333723433629,-1,dn,NF-κB,PKCθ–IKK–NF-κβ pathway,4,NFKB complex,28,32,NFKB1 | NF-κB,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,72,bortezomib,dmso,180,NFKBIA,-0.00105576258001498,-0.116697155476034,-0.0328186102058751,0.88442258486183,0.911500900650648,-1,dn,IκBɑ,PKCθ–IKK–NF-κβ pathway,4,NFKB complex,26,30,NFKBIA | IκBɑ,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,72,bortezomib,dmso,180,PAG1,-0.238548251535586,-1.08971454338691,-0.531101183286134,2.42863238480409e-07,3.80174377159718e-06,-1,dn,,Initial TCR Response,5,TCR Regulator,46,51,PAG1,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,72,bortezomib,dmso,180,PDPK1,0.0798601627803171,0.354448407759663,0.0941503775499523,0.09313035169982,0.197744645273936,1,up,PDK1,PKCθ–IKK–NF-κβ pathway,4,CBM complex activator,35,39,PDPK1 | PDK1,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,72,bortezomib,dmso,180,PLCG1,-0.0121714701429397,-1.23962838534291,-0.165431123715039,0.000787137636226969,0.00493559551454922,-1,dn,PLC-γ1,Initial TCR Response,5,Phospholipase C complex,39,44,PLCG1 | PLC-γ1,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,72,bortezomib,dmso,180,PLCG2,-0.107883526568507,-0.921800005594945,-0.338919471102757,6.48353105052029e-05,0.000563626573071443,-1,dn,PLC-γ2,Initial TCR Response,5,Phospholipase C complex,38,43,PLCG2 | PLC-γ2,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,72,bortezomib,dmso,180,PPP3CA,-0.109263536868345,-1.19093901957412,-0.563767652710172,3.11892109104057e-07,4.70612411983493e-06,-1,dn,,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,24,27,PPP3CA,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,72,bortezomib,dmso,180,PPP3CB,0.0925669771807632,-0.957336374080111,-0.266376050641732,0.000119024012210255,0.000955396193233677,-1,dn,,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,23,26,PPP3CB,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,72,bortezomib,dmso,180,PPP3CC,0.0192528690024681,0.0983304995387557,0.0493724856720129,0.853120287063779,0.888829523903394,1,up,,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,22,25,PPP3CC,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,72,bortezomib,dmso,180,PRKCQ,-0.143779312385612,-1.06290089666937,-0.464146487525278,3.32084676507603e-06,3.98435194226535e-05,-1,dn,PKC-Θ,PKCθ–IKK–NF-κβ pathway,4,CBM complex activator,37,41,PRKCQ | PKC-Θ,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,72,bortezomib,dmso,180,PTPN22,0.0920723208147828,-2.2173441740316,-0.52229419578768,6.53982121569834e-16,3.04987287319599e-14,-1,dn,Lyp/Pep,Initial TCR Response,5,TCR Negative Regulator,47,52,PTPN22 | Lyp/Pep,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,72,bortezomib,dmso,180,PTPRC,-0.771677772984576,-4.35828636846642,-1.18531548125505,5.81372055570693e-42,1.85914478056428e-39,-1,dn,CD45,Initial TCR Response,5,TCR Activator,49,54,PTPRC | CD45,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,72,bortezomib,dmso,180,PTPRJ,-0.0237805669783873,-0.690516442475441,-0.222197507221768,0.0138117639100308,0.0490756087501651,-1,dn,CD148,Initial TCR Response,5,TCR Activator,50,55,PTPRJ | CD148,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,72,bortezomib,dmso,180,RAF1,0.0914200634453689,0.340486518102272,0.15679933846636,0.0794360581833964,0.17680101043354,1,up,c-RAF,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,16,18,RAF1 | c-RAF,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,72,bortezomib,dmso,180,RASGRP1,-0.0202436689491294,-0.580847926638279,-0.229332561272446,0.0270705473346471,0.0817227514613724,-1,dn,,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,18,20,RASGRP1,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,72,bortezomib,dmso,180,RELA,0.0318744736950601,0.296566640418626,0.0263808354799838,0.706773693503763,0.776687733386437,1,up,p65,PKCθ–IKK–NF-κβ pathway,4,NFKB complex,27,31,RELA | p65,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,72,bortezomib,dmso,180,RICTOR,0.194694924410918,0.381548193040136,0.267893664482014,0.00115841029986434,0.00683643823984803,1,up,,mTORC pathways,0,mTORC2 complex,1,1,RICTOR,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,72,bortezomib,dmso,180,RPTOR,0.328289048264212,1.16403517992659,0.594851505097296,1.11961289303545e-13,4.17708910176642e-12,1,up,,mTORC pathways,0,mTORC1 complex,4,4,RPTOR,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,72,bortezomib,dmso,180,SOS1,-0.947643559161291,-2.41108230482686,-1.10243502777659,3.10004255839829e-41,9.57164864410286e-39,-1,dn,,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,17,19,SOS1,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,72,bortezomib,dmso,180,TRAC,-0.108623346817278,-1.50938027092386,-0.526034270002885,4.78969646005544e-11,1.29177536455833e-09,-1,dn,TCRɑ,Initial TCR Response,5,TCR complex,58,63,TRAC | TCRɑ,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,72,bortezomib,dmso,180,TRAF6,0.0652755457298516,0.242180314785091,0.0641897371882523,0.37421979362776,0.500188689676514,1,up,,PKCθ–IKK–NF-κβ pathway,4,CBM complex,32,36,TRAF6,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,72,bortezomib,dmso,180,TRBC1,-0.192059452963128,-1.10822500984669,-0.239310116316271,0.000199626957147404,0.00151351378009979,-1,dn,TCRβ,Initial TCR Response,5,TCR complex,59,64,TRBC1 | TCRβ,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,72,bortezomib,dmso,180,TXK,-0.0986000350310532,-1.34094711520186,-0.400706647047716,3.1219988018561e-07,4.70612411983493e-06,-1,dn,,Initial TCR Response,5,Phospholipase C complex,40,45,TXK,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_em,72,bortezomib,dmso,180,ZAP70,0.0512493311319708,-0.748618800230611,-0.142927737361848,0.015449899204525,0.0534125086785008,-1,dn,,Initial TCR Response,5,TCR Output,45,50,ZAP70,Bor/DMSO,CD4 EM,#1C75BC,3,5
t_cd4_naive,72,bortezomib,dmso,1352,BCL10,0.0407108181875896,0.00492250478075621,0.00321657025734745,0.452342580455664,0.464560481897782,1,up,,PKCθ–IKK–NF-κβ pathway,4,CBM complex,36,40,BCL10,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,72,bortezomib,dmso,1352,CARD11,0.0474302125297649,0.0550213563696129,0.0498681871828978,0.143537931455172,0.157691970024112,1,up,CARMA1,PKCθ–IKK–NF-κβ pathway,4,CBM complex,34,38,CARD11 | CARMA1,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,72,bortezomib,dmso,1352,CD247,-0.0241389118290987,-0.530086294500204,-0.152177123408991,1.00689911202165e-05,2.43613156437462e-05,-1,dn,CD3ζ,Initial TCR Response,5,TCR complex,56,61,CD247 | CD3ζ,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,72,bortezomib,dmso,1352,CD3D,0.0639384498921246,-0.320868267652869,-0.0886219177477945,3.49145512997262e-06,9.03266903006963e-06,-1,dn,CD3δ,Initial TCR Response,5,TCR complex,60,65,CD3D | CD3δ,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,72,bortezomib,dmso,1352,CD3E,-0.0579462479171991,-1.57136798325278,-0.478959207666031,9.99371585580501e-66,3.39499634134294e-64,-1,dn,CD3ε,Initial TCR Response,5,TCR complex,61,66,CD3E | CD3ε,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,72,bortezomib,dmso,1352,CD3G,-0.0574148712180796,-1.90192691929667,-0.577299045570763,7.57208673179257e-89,3.972470058217e-87,-1,dn,CD3γ,Initial TCR Response,5,TCR complex,57,62,CD3G | CD3γ,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,72,bortezomib,dmso,1352,CD4,-0.0245090269645709,-1.00375649404252,-0.281437365809028,1.51532859515815e-25,1.55260305627514e-24,-1,dn,,Initial TCR Response,5,TCR Coreceptor,55,60,CD4,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,72,bortezomib,dmso,1352,CHUK,0.0262210895859948,0.625879715711766,0.102783253905299,1.63731421373401e-06,4.41986268209739e-06,1,up,IKKɑ,PKCθ–IKK–NF-κβ pathway,4,IKb Kinase complex,30,34,CHUK | IKKɑ,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,72,bortezomib,dmso,1352,CSK,0.0378751352436683,-0.462280010747227,-0.0606831719865444,0.000414049133728714,0.000758297231435552,-1,dn,,Initial TCR Response,5,TCR Negative Regulator,48,53,CSK,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,72,bortezomib,dmso,1352,DGKA,0.0224966637272798,-0.708640085147695,-0.244936652416193,2.61336013021122e-16,1.66120721773932e-15,-1,dn,DGKɑ,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,19,22,DGKA | DGKɑ,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,72,bortezomib,dmso,1352,FYN,0.131930519899171,0.0760404187256267,0.128967254328743,7.37831383369473e-08,2.34414884505541e-07,1,up,,Initial TCR Response,5,ITAM-targeting Kinase,51,56,FYN,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,72,bortezomib,dmso,1352,GRAP2,-0.160433990943918,-1.8739560505753,-0.773245277975286,1.10042399534889e-107,8.29219499767901e-106,-1,dn,GADS,Initial TCR Response,5,Phospholipase C complex,42,47,GRAP2 | GADS,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,72,bortezomib,dmso,1352,IKBKB,0.0289629093562705,-0.336016410725161,-0.0753725481825497,0.00156487712905104,0.00254538197070331,-1,dn,IKKβ,PKCθ–IKK–NF-κβ pathway,4,IKb Kinase complex,31,35,IKBKB | IKKβ,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,72,bortezomib,dmso,1352,IKBKG,0.0520995836365575,0.579281676687374,0.030457063490377,0.00896960815436453,0.0125314481698176,1,up,IKKγ,PKCθ–IKK–NF-κβ pathway,4,IKb Kinase complex,29,33,IKBKG | IKKγ,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,72,bortezomib,dmso,1352,ITK,-0.289341109707642,-2.2662897907067,-1.05794996819583,2.10858109555194e-172,3.23667198167222e-170,-1,dn,,Initial TCR Response,5,Phospholipase C complex,41,46,ITK,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,72,bortezomib,dmso,1352,JUN,0.0838559097590232,0.854890914340379,0.155614387310506,6.13665805141151e-13,3.09596826464699e-12,1,up,c-Jun,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,21,24,JUN | c-Jun,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,72,bortezomib,dmso,1352,LAT,0.00301407065320033,-1.70451456423738,-0.277757078809768,2.90208922476371e-43,5.41788684325819e-42,-1,dn,,Initial TCR Response,5,Phospholipase C complex,43,48,LAT,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,72,bortezomib,dmso,1352,LCK,-0.0166335252369938,-1.56563688590852,-0.404204040658484,4.06607566262388e-54,1.03385586403341e-52,-1,dn,,Initial TCR Response,5,ITAM-targeting Kinase,52,57,LCK,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,72,bortezomib,dmso,1352,LCP2,-0.0817107621638949,-1.2038633725676,-0.468662246120199,5.60823502725435e-47,1.1650792015266e-45,-1,dn,SLP-76,Initial TCR Response,5,Phospholipase C complex,44,49,LCP2 | SLP-76,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,72,bortezomib,dmso,1352,MALT1,-0.126858982118761,-0.892863254097846,-0.453959434859244,1.38835962011676e-32,1.83835669187665e-31,-1,dn,,PKCθ–IKK–NF-κβ pathway,4,CBM complex,33,37,MALT1,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,72,bortezomib,dmso,1352,MAP2K1,0.15907701375839,0.565092941620804,0.255387238944511,4.88803330249447e-17,3.27541698014363e-16,1,up,MEK1,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,15,17,MAP2K1 | MEK1,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,72,bortezomib,dmso,1352,MAP2K2,0.081344683281123,0.543215848052407,0.0815521570053136,4.46597983955292e-07,1.29525916340287e-06,1,up,MEK2,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,14,16,MAP2K2 | MEK2,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,72,bortezomib,dmso,1352,MAP2K7,0.0701120703645372,-0.0903287732127169,-0.004069390245134,0.0306359912480472,0.0382442366649191,-1,dn,MKK7,p38 and JNK pathways,1,JNK activation complex,9,10,MAP2K7 | MKK7,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,72,bortezomib,dmso,1352,MAP3K7,0.114416366301596,0.532755023901542,0.228010350435592,3.35132021974955e-14,1.84701418228085e-13,1,up,TAK1,p38 and JNK pathways,1,JNK activation complex,10,11,MAP3K7 | TAK1,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,72,bortezomib,dmso,1352,MAPK1,0.0821315726262609,0.0398053068956924,0.0396190382482203,0.0012006060771964,0.00199715508205518,1,up,ERK2,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,13,15,MAPK1 | ERK2,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,72,bortezomib,dmso,1352,MAPK14,0.0170577840949305,-0.209547232692133,-0.0737627882470809,0.031285031718311,0.0389898703823605,-1,dn,p38ɑ,p38 and JNK pathways,1,p38,11,12,MAPK14 | p38ɑ,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,72,bortezomib,dmso,1352,MAPK8,0.236193103255095,1.20424574333661,0.671193343175586,2.60849129765198e-60,7.80569832716147e-59,1,up,JNK1,p38 and JNK pathways,1,JNK activation complex,7,8,MAPK8 | JNK1,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,72,bortezomib,dmso,1352,MAPK9,-0.00989004132161224,0.206412051075435,0.0302679667953815,0.227738029621012,0.242295023428131,1,up,JNK2,p38 and JNK pathways,1,JNK activation complex,8,9,MAPK9 | JNK2,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,72,bortezomib,dmso,1352,MAPKAP1,0.151214363710809,0.312841390069542,0.194570679067295,1.63395784738344e-12,7.98107047552231e-12,1,up,,mTORC pathways,0,mTORC2 complex,3,3,MAPKAP1,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,72,bortezomib,dmso,1352,MTOR,0.122008428476911,0.454768084889647,0.142894920615641,1.24220814592942e-10,5.18201475672319e-10,1,up,,mTORC pathways,0,mTORC1 complex,5,5,MTOR,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,72,bortezomib,dmso,1352,NFATC1,0.0185273661665131,-0.169263560245522,-0.0275603301050574,0.278869212134963,0.293567043356199,-1,dn,,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,25,28,NFATC1,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,72,bortezomib,dmso,1352,NFKB1,-0.0286902871049949,-0.5277509597308,-0.248053073633584,3.83910994748579e-10,1.54028956218343e-09,-1,dn,NF-κB,PKCθ–IKK–NF-κβ pathway,4,NFKB complex,28,32,NFKB1 | NF-κB,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,72,bortezomib,dmso,1352,NFKBIA,0.145726692324069,0.538730931869306,0.131157357584142,2.72339749033204e-12,1.31093157940548e-11,1,up,IκBɑ,PKCθ–IKK–NF-κβ pathway,4,NFKB complex,26,30,NFKBIA | IκBɑ,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,72,bortezomib,dmso,1352,PAG1,0.0287388618010805,-0.466211677375437,-0.183941849685942,4.31862813719458e-08,1.41490547941525e-07,-1,dn,,Initial TCR Response,5,TCR Regulator,46,51,PAG1,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,72,bortezomib,dmso,1352,PDPK1,0.0715323041956576,0.290736667984348,0.0482757682343662,0.000259395956284699,0.000494427984147051,1,up,PDK1,PKCθ–IKK–NF-κβ pathway,4,CBM complex activator,35,39,PDPK1 | PDK1,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,72,bortezomib,dmso,1352,PLCG1,0.0397766502319148,-0.527744775231349,-0.0712587359918515,1.84022712535223e-05,4.2560386836062e-05,-1,dn,PLC-γ1,Initial TCR Response,5,Phospholipase C complex,39,44,PLCG1 | PLC-γ1,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,72,bortezomib,dmso,1352,PLCG2,-0.282745539269588,-1.56136388078809,-0.666849920216729,1.70569576784957e-89,9.18085209071759e-88,-1,dn,PLC-γ2,Initial TCR Response,5,Phospholipase C complex,38,43,PLCG2 | PLC-γ2,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,72,bortezomib,dmso,1352,PPP3CA,-0.0221154582756079,-0.705005262293121,-0.319190545340344,4.27194608296605e-17,2.87420138650208e-16,-1,dn,,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,24,27,PPP3CA,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,72,bortezomib,dmso,1352,PPP3CB,0.0352955130994847,-0.565660670316298,-0.182735355806435,4.72012233184302e-10,1.87830504122164e-09,-1,dn,,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,23,26,PPP3CB,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,72,bortezomib,dmso,1352,PPP3CC,0.0755777077114174,-0.0753492485211578,0.00878700047318104,0.00269246903624951,0.0041684489804767,1,up,,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,22,25,PPP3CC,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,72,bortezomib,dmso,1352,PRKCQ,0.0610549968543886,-0.479089949639465,-0.168290495037325,1.58836575734952e-09,6.01460199299688e-09,-1,dn,PKC-Θ,PKCθ–IKK–NF-κβ pathway,4,CBM complex activator,37,41,PRKCQ | PKC-Θ,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,72,bortezomib,dmso,1352,PTPN22,-0.11045127545006,-2.0253281526223,-0.361254031604061,1.59708245978503e-59,4.62874703117415e-58,-1,dn,Lyp/Pep,Initial TCR Response,5,TCR Negative Regulator,47,52,PTPN22 | Lyp/Pep,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,72,bortezomib,dmso,1352,PTPRC,-0.596481936504611,-2.22694104597889,-0.964627172185242,2.50926034414911e-181,4.24474673319428e-179,-1,dn,CD45,Initial TCR Response,5,TCR Activator,49,54,PTPRC | CD45,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,72,bortezomib,dmso,1352,PTPRJ,0.0473013034335888,-0.368017194353689,-0.090703123062876,0.000266309178979955,0.0005065251915018,-1,dn,CD148,Initial TCR Response,5,TCR Activator,50,55,PTPRJ | CD148,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,72,bortezomib,dmso,1352,RAF1,0.0607493212153517,0.0619641574949743,0.0453798895374115,0.0231076725355475,0.0295585644517212,1,up,c-RAF,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,16,18,RAF1 | c-RAF,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,72,bortezomib,dmso,1352,RASGRP1,0.10726644372957,0.0661968524714274,0.0758380698372267,2.08616445036699e-05,4.7900878473939e-05,1,up,,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,18,20,RASGRP1,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,72,bortezomib,dmso,1352,RELA,0.0672130722221046,0.540544873614284,0.0307146310341699,0.00646844738714031,0.00929881380367777,1,up,p65,PKCθ–IKK–NF-κβ pathway,4,NFKB complex,27,31,RELA | p65,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,72,bortezomib,dmso,1352,RICTOR,0.137106641561163,0.14063795804322,0.152204273420624,1.11922233030426e-09,4.304980926168e-09,1,up,,mTORC pathways,0,mTORC2 complex,1,1,RICTOR,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,72,bortezomib,dmso,1352,RPTOR,0.226666683581717,1.1770710698252,0.574275382382417,2.02927090816906e-61,6.20687326856582e-60,1,up,,mTORC pathways,0,mTORC1 complex,4,4,RPTOR,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,72,bortezomib,dmso,1352,SOS1,-0.462362225372863,-1.37520584263584,-0.713129427086441,6.41797560236697e-95,3.79989998342999e-93,-1,dn,,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,17,19,SOS1,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,72,bortezomib,dmso,1352,TRAC,-0.0900173820603623,-1.19250595442401,-0.465574224404884,1.6677228721599e-47,3.53548718346123e-46,-1,dn,TCRɑ,Initial TCR Response,5,TCR complex,58,63,TRAC | TCRɑ,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,72,bortezomib,dmso,1352,TRAF6,0.0571726165948848,0.501144012671634,0.0979532610465525,7.7550301673689e-06,1.90916082736326e-05,1,up,,PKCθ–IKK–NF-κβ pathway,4,CBM complex,32,36,TRAF6,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,72,bortezomib,dmso,1352,TRBC1,-0.249187316171582,-1.30101700895435,-0.386684658905742,3.28428705754154e-43,6.11763043145209e-42,-1,dn,TCRβ,Initial TCR Response,5,TCR complex,59,64,TRBC1 | TCRβ,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,72,bortezomib,dmso,1352,TXK,-0.128663424664565,-1.20350959446194,-0.630696304744853,1.43308449454383e-51,3.31811099867984e-50,-1,dn,,Initial TCR Response,5,Phospholipase C complex,40,45,TXK,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_naive,72,bortezomib,dmso,1352,ZAP70,0.0478483104661403,-0.80621738868419,-0.141257491800053,1.0207416071567e-13,5.44461208605011e-13,-1,dn,,Initial TCR Response,5,TCR Output,45,50,ZAP70,Bor/DMSO,CD4 Naive,#93A7D1,1,7
t_cd4_treg,72,bortezomib,dmso,78,BCL10,-0.010003914654949,-0.0208758584512727,-0.00334259646094145,0.995899799261044,0.997758433204115,-1,dn,,PKCθ–IKK–NF-κβ pathway,4,CBM complex,36,40,BCL10,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,72,bortezomib,dmso,78,CARD11,-0.00285089254759685,-0.0977279050524162,-0.0409833603633177,0.954933445472966,0.980019764687048,-1,dn,CARMA1,PKCθ–IKK–NF-κβ pathway,4,CBM complex,34,38,CARD11 | CARMA1,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,72,bortezomib,dmso,78,CD247,-0.23449464320273,-1.01179642616321,-0.453405724500137,0.00662803165997001,0.0749534286603301,-1,dn,CD3ζ,Initial TCR Response,5,TCR complex,56,61,CD247 | CD3ζ,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,72,bortezomib,dmso,78,CD3D,-0.16184833419176,-0.882869985474113,-0.451398063393415,0.00642069431573888,0.0732440704067912,-1,dn,CD3δ,Initial TCR Response,5,TCR complex,60,65,CD3D | CD3δ,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,72,bortezomib,dmso,78,CD3E,0.0324999253698302,-1.45857244871167,-0.412699528391788,0.00051087344724195,0.0119074696016372,-1,dn,CD3ε,Initial TCR Response,5,TCR complex,61,66,CD3E | CD3ε,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,72,bortezomib,dmso,78,CD3G,0.0596129632634964,-1.51209335678505,-0.447338423311169,0.000258874013345126,0.0069895983603184,-1,dn,CD3γ,Initial TCR Response,5,TCR complex,57,62,CD3G | CD3γ,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,72,bortezomib,dmso,78,CD4,-0.18248252257691,-1.5251229576168,-0.362534431015916,0.00058810242587291,0.0132847097488024,-1,dn,,Initial TCR Response,5,TCR Coreceptor,55,60,CD4,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,72,bortezomib,dmso,78,CHUK,0.20951825189058,0.646522576645455,0.128651720586885,0.16812501076237,0.497667482392926,1,up,IKKɑ,PKCθ–IKK–NF-κβ pathway,4,IKb Kinase complex,30,34,CHUK | IKKɑ,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,72,bortezomib,dmso,78,CSK,-0.0170240860496988,-1.22857144057305,-0.226613767125296,0.0199061154109367,0.149271330517838,-1,dn,,Initial TCR Response,5,TCR Negative Regulator,48,53,CSK,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,72,bortezomib,dmso,78,DGKA,-0.139863198580445,-1.15906951013671,-0.356270763871125,0.0055287714872801,0.0669171997253557,-1,dn,DGKɑ,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,19,22,DGKA | DGKɑ,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,72,bortezomib,dmso,78,ELK1,0.0064770233141301,0.0246826574411336,0.00255555326470383,0.999167247539156,0.999406308503678,1,up,,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,12,14,ELK1,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,72,bortezomib,dmso,78,FYN,0.157645862801897,0.780569514951536,0.317827776353556,0.0598021503502018,0.277410868984395,1,up,,Initial TCR Response,5,ITAM-targeting Kinase,51,56,FYN,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,72,bortezomib,dmso,78,GRAP2,0.0618527455782302,-1.4414941643865,-0.370735197523246,0.00126518364607182,0.0234676137277467,-1,dn,GADS,Initial TCR Response,5,Phospholipase C complex,42,47,GRAP2 | GADS,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,72,bortezomib,dmso,78,IKBKB,0.176430441721905,0.381808932907306,0.101308784195536,0.187898726876855,0.527106592353332,1,up,IKKβ,PKCθ–IKK–NF-κβ pathway,4,IKb Kinase complex,31,35,IKBKB | IKKβ,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,72,bortezomib,dmso,78,IKBKG,0.0878957116485139,0.643890440187013,0.0450518896544578,0.597135546505101,0.839670107458483,1,up,IKKγ,PKCθ–IKK–NF-κβ pathway,4,IKb Kinase complex,29,33,IKBKG | IKKγ,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,72,bortezomib,dmso,78,ITK,-0.247686609695924,-1.83266177051945,-0.87351417062186,9.04878191788413e-08,9.07463558050666e-06,-1,dn,,Initial TCR Response,5,Phospholipase C complex,41,46,ITK,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,72,bortezomib,dmso,78,JUN,0.268362236816042,0.287235997175754,0.104605628104188,0.0840412560471757,0.339513281401738,1,up,c-Jun,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,21,24,JUN | c-Jun,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,72,bortezomib,dmso,78,LAT,-0.00108391187348813,-1.4273357903693,-0.221980307437243,0.0108005487501069,0.102849591272585,-1,dn,,Initial TCR Response,5,Phospholipase C complex,43,48,LAT,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,72,bortezomib,dmso,78,LCK,-0.0228178563035836,-2.24431465063592,-0.540340397720427,7.29134536206225e-07,5.28101728366509e-05,-1,dn,,Initial TCR Response,5,ITAM-targeting Kinase,52,57,LCK,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,72,bortezomib,dmso,78,LCP2,-0.136893946946125,-1.72217973036705,-0.721131297965758,1.89179316148073e-06,0.000116652056700494,-1,dn,SLP-76,Initial TCR Response,5,Phospholipase C complex,44,49,LCP2 | SLP-76,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,72,bortezomib,dmso,78,MALT1,0.0294667248007554,-0.427140645386551,-0.164024289016584,0.410841525850139,0.741124661996957,-1,dn,,PKCθ–IKK–NF-κβ pathway,4,CBM complex,33,37,MALT1,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,72,bortezomib,dmso,78,MAP2K1,-0.0173621359751291,-0.236830758452098,-0.0966216625611644,0.787174132400724,0.921127289138876,-1,dn,MEK1,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,15,17,MAP2K1 | MEK1,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,72,bortezomib,dmso,78,MAP2K2,-0.0269522918022241,-0.0296226509314838,-0.00965230407281917,0.968106445367293,0.986489311610148,-1,dn,MEK2,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,14,16,MAP2K2 | MEK2,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,72,bortezomib,dmso,78,MAP2K7,-0.0654198052710219,-0.529890209187834,-0.0572434338892133,0.616391702163698,0.846984132870017,-1,dn,MKK7,p38 and JNK pathways,1,JNK activation complex,9,10,MAP2K7 | MKK7,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,72,bortezomib,dmso,78,MAP3K7,0.087753444913681,0.915645834064621,0.320067023989221,0.0271924232228145,0.17562494998684,1,up,TAK1,p38 and JNK pathways,1,JNK activation complex,10,11,MAP3K7 | TAK1,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,72,bortezomib,dmso,78,MAPK1,0.0276951362547124,0.577532995097259,0.248387713495241,0.220396960319529,0.568657806015272,1,up,ERK2,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,13,15,MAPK1 | ERK2,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,72,bortezomib,dmso,78,MAPK14,0.086332774864866,-0.110478954845511,-0.011487931638044,0.724275601038262,0.894396920503516,-1,dn,p38ɑ,p38 and JNK pathways,1,p38,11,12,MAPK14 | p38ɑ,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,72,bortezomib,dmso,78,MAPK8,0.112120312987397,0.847391333906693,0.446689053674907,0.0259956235670451,0.170833755492395,1,up,JNK1,p38 and JNK pathways,1,JNK activation complex,7,8,MAPK8 | JNK1,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,72,bortezomib,dmso,78,MAPK9,0.202514275137525,0.212552548231148,0.0705532438234573,0.304682602706735,0.6557861868636,1,up,JNK2,p38 and JNK pathways,1,JNK activation complex,8,9,MAPK9 | JNK2,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,72,bortezomib,dmso,78,MAPKAP1,0.249143401609757,0.776048864776229,0.407460936941511,0.00310514842146148,0.045123542188308,1,up,,mTORC pathways,0,mTORC2 complex,3,3,MAPKAP1,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,72,bortezomib,dmso,78,MTOR,0.265789454496764,0.296039971746279,0.146539233282132,0.0273409229944611,0.176459167784619,1,up,,mTORC pathways,0,mTORC1 complex,5,5,MTOR,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,72,bortezomib,dmso,78,NFATC1,0.223475134638451,0.253788701277646,0.0597631799715064,0.514880999074186,0.801766502102011,1,up,,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,25,28,NFATC1,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,72,bortezomib,dmso,78,NFKB1,0.0855047818477578,-0.271950771625591,-0.0662769013811398,0.442759962153851,0.759231006128531,-1,dn,NF-κB,PKCθ–IKK–NF-κβ pathway,4,NFKB complex,28,32,NFKB1 | NF-κB,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,72,bortezomib,dmso,78,NFKBIA,0.0707935892916904,0.828363799406851,0.229575508797729,0.0631538752923427,0.284971319660761,1,up,IκBɑ,PKCθ–IKK–NF-κβ pathway,4,NFKB complex,26,30,NFKBIA | IκBɑ,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,72,bortezomib,dmso,78,PAG1,-0.298495300921256,-1.03491305225244,-0.627321047621009,0.000271545257496492,0.00725321992592815,-1,dn,,Initial TCR Response,5,TCR Regulator,46,51,PAG1,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,72,bortezomib,dmso,78,PDPK1,0.0486661591688647,-0.317885996252137,-0.0538237817243191,0.690214707872122,0.881334745213514,-1,dn,PDK1,PKCθ–IKK–NF-κβ pathway,4,CBM complex activator,35,39,PDPK1 | PDK1,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,72,bortezomib,dmso,78,PLCG1,0.0372017473766765,-1.34578687413228,-0.147897543899073,0.0448847309820954,0.234974890254655,-1,dn,PLC-γ1,Initial TCR Response,5,Phospholipase C complex,39,44,PLCG1 | PLC-γ1,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,72,bortezomib,dmso,78,PLCG2,-0.184757246545499,-1.29952465220239,-0.623720049046885,0.000152649699882842,0.00447936064672287,-1,dn,PLC-γ2,Initial TCR Response,5,Phospholipase C complex,38,43,PLCG2 | PLC-γ2,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,72,bortezomib,dmso,78,PPP3CA,-0.020301210267824,-1.47528632829776,-0.672093566693819,8.44156912459161e-05,0.00280137308476448,-1,dn,,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,24,27,PPP3CA,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,72,bortezomib,dmso,78,PPP3CB,-0.0273733344915461,-0.620758572710764,-0.224193389567447,0.204019470599507,0.549977886878664,-1,dn,,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,23,26,PPP3CB,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,72,bortezomib,dmso,78,PPP3CC,0.0591623692151911,0.124964280325332,0.08410702365595,0.790002105908375,0.921820639115182,1,up,,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,22,25,PPP3CC,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,72,bortezomib,dmso,78,PRKCQ,-0.20444564229277,-1.25940073741269,-0.655845494648016,0.000271816920301055,0.00725321992592815,-1,dn,PKC-Θ,PKCθ–IKK–NF-κβ pathway,4,CBM complex activator,37,41,PRKCQ | PKC-Θ,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,72,bortezomib,dmso,78,PRR5,0.32840240108652,0.19846457408412,0.0214972677825306,0.449407628405854,0.76441927636414,1,up,,mTORC pathways,0,mTORC2 complex,2,2,PRR5,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,72,bortezomib,dmso,78,PTPN22,0.067479304070304,-3.07721332155443,-0.500185707279748,4.86498144692007e-08,5.28545484340388e-06,-1,dn,Lyp/Pep,Initial TCR Response,5,TCR Negative Regulator,47,52,PTPN22 | Lyp/Pep,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,72,bortezomib,dmso,78,PTPRC,-0.655049741720058,-1.82865368666116,-1.06307229822005,1.76738678907293e-10,3.43173868874034e-08,-1,dn,CD45,Initial TCR Response,5,TCR Activator,49,54,PTPRC | CD45,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,72,bortezomib,dmso,78,PTPRJ,0.129605938565941,-0.202672824271781,-0.021254986405031,0.369027224775619,0.71460070939006,-1,dn,CD148,Initial TCR Response,5,TCR Activator,50,55,PTPRJ | CD148,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,72,bortezomib,dmso,78,RAF1,-0.00505621821365419,0.403928131224574,0.158762099687673,0.478137347334609,0.782969470593394,1,up,c-RAF,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,16,18,RAF1 | c-RAF,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,72,bortezomib,dmso,78,RASGRP1,0.0434222151184285,0.0142062315788359,0.0301664842574602,0.903776469486584,0.96364809680273,1,up,,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,18,20,RASGRP1,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,72,bortezomib,dmso,78,RELA,0.0603738297964542,0.131385907001505,0.0131377028071845,0.936137937323693,0.974072150353845,1,up,p65,PKCθ–IKK–NF-κβ pathway,4,NFKB complex,27,31,RELA | p65,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,72,bortezomib,dmso,78,RICTOR,0.213780732305179,0.022598999819271,0.153003714327047,0.064842345318229,0.288912119341425,1,up,,mTORC pathways,0,mTORC2 complex,1,1,RICTOR,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,72,bortezomib,dmso,78,RPTOR,0.296070774303477,1.66107038881762,0.713362199741735,3.94879793917064e-07,3.24655225161002e-05,1,up,,mTORC pathways,0,mTORC1 complex,4,4,RPTOR,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,72,bortezomib,dmso,78,SOS1,-0.281483929041042,-0.720581047650162,-0.466933058369644,0.00761060242045139,0.0830793752261236,-1,dn,,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,17,19,SOS1,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,72,bortezomib,dmso,78,TRAC,-0.264075977217781,-1.97713598965062,-0.80162094053293,3.62159489243709e-08,4.18362974536467e-06,-1,dn,TCRɑ,Initial TCR Response,5,TCR complex,58,63,TRAC | TCRɑ,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,72,bortezomib,dmso,78,TRAF6,0.150810954142874,0.534242651481853,0.110656582451986,0.323739634746423,0.673745851084401,1,up,,PKCθ–IKK–NF-κβ pathway,4,CBM complex,32,36,TRAF6,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,72,bortezomib,dmso,78,TRBC1,-0.463262361655552,-1.63021083952959,-0.473087578872615,0.000289189263012892,0.00761518304523284,-1,dn,TCRβ,Initial TCR Response,5,TCR complex,59,64,TRBC1 | TCRβ,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,72,bortezomib,dmso,78,TXK,-0.274154983896645,-0.776415373842774,-0.431100869066049,0.0112118157589698,0.105364927258873,-1,dn,,Initial TCR Response,5,Phospholipase C complex,40,45,TXK,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd4_treg,72,bortezomib,dmso,78,ZAP70,0.15501989061207,-0.223471560782827,-0.0176796084598657,0.230618783461067,0.580106675266179,-1,dn,,Initial TCR Response,5,TCR Output,45,50,ZAP70,Bor/DMSO,CD4 Treg,#E57A93,4,4
t_cd8_memory,72,bortezomib,dmso,163,BCL10,0.0680270936729831,0.628388369300216,0.096363438748287,0.149155719360863,0.340195258650753,1,up,,PKCθ–IKK–NF-κβ pathway,4,CBM complex,36,40,BCL10,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,72,bortezomib,dmso,163,CARD11,-0.00842762240243387,0.0572496324611674,0.020751977310277,0.962317136795892,0.980199336153321,1,up,CARMA1,PKCθ–IKK–NF-κβ pathway,4,CBM complex,34,38,CARD11 | CARMA1,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,72,bortezomib,dmso,163,CD247,0.106107856245602,-0.102759525269497,0.0422433935289668,0.272076580621464,0.490484451069252,1,up,CD3ζ,Initial TCR Response,5,TCR complex,56,61,CD247 | CD3ζ,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,72,bortezomib,dmso,163,CD3D,-0.0242368751771814,-0.596770913483218,-0.251611554192382,0.0363673508970622,0.132189107068819,-1,dn,CD3δ,Initial TCR Response,5,TCR complex,60,65,CD3D | CD3δ,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,72,bortezomib,dmso,163,CD3E,0.0233848399665131,-1.62289109733945,-0.415071820249381,8.28511491899355e-09,2.72945073208187e-07,-1,dn,CD3ε,Initial TCR Response,5,TCR complex,61,66,CD3E | CD3ε,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,72,bortezomib,dmso,163,CD3G,0.0158449029482809,-1.61599885319211,-0.396974319128115,4.00480463159704e-08,1.16694455750397e-06,-1,dn,CD3γ,Initial TCR Response,5,TCR complex,57,62,CD3G | CD3γ,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,72,bortezomib,dmso,163,CD8A,-0.190602766582648,-2.13043178926653,-0.726139286319539,1.36465231757764e-16,1.35376576538123e-14,-1,dn,CD8ɑ,Initial TCR Response,5,TCR Coreceptor,54,59,CD8A | CD8ɑ,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,72,bortezomib,dmso,163,CD8B,-0.0962642761641197,-1.15242787873576,-0.48750428148621,1.70049858756021e-06,3.42778585149979e-05,-1,dn,CD8β,Initial TCR Response,5,TCR Coreceptor,53,58,CD8B | CD8β,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,72,bortezomib,dmso,163,CHUK,-0.000494886916810193,0.704490199637258,0.130090126525939,0.0700244581982925,0.208163616644015,1,up,IKKɑ,PKCθ–IKK–NF-κβ pathway,4,IKb Kinase complex,30,34,CHUK | IKKɑ,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,72,bortezomib,dmso,163,CSK,0.140810213968164,-0.592458973379332,-0.094702552669615,0.0492547392299139,0.164118101495152,-1,dn,,Initial TCR Response,5,TCR Negative Regulator,48,53,CSK,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,72,bortezomib,dmso,163,DGKA,-0.0452235394193701,-0.529835033377109,-0.128846490636919,0.131524243239637,0.315379560989342,-1,dn,DGKɑ,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,19,22,DGKA | DGKɑ,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,72,bortezomib,dmso,163,FYN,-0.195838610876137,-1.18770272937815,-0.513519691273249,6.16613895617101e-06,0.000108270926727335,-1,dn,,Initial TCR Response,5,ITAM-targeting Kinase,51,56,FYN,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,72,bortezomib,dmso,163,GRAP2,-0.325340978982837,-2.36291584152076,-1.12981007254737,1.73471875977686e-23,4.13941403515402e-21,-1,dn,GADS,Initial TCR Response,5,Phospholipase C complex,42,47,GRAP2 | GADS,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,72,bortezomib,dmso,163,IKBKB,-0.0258551125574282,-0.592315518201684,-0.158607688879554,0.0710735964522566,0.209728871349256,-1,dn,IKKβ,PKCθ–IKK–NF-κβ pathway,4,IKb Kinase complex,31,35,IKBKB | IKKβ,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,72,bortezomib,dmso,163,IKBKG,-0.152575845531069,-0.393665454708591,-0.0504102520561038,0.401981954318002,0.612758749080394,-1,dn,IKKγ,PKCθ–IKK–NF-κβ pathway,4,IKb Kinase complex,29,33,IKBKG | IKKγ,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,72,bortezomib,dmso,163,ITK,-0.308266918723569,-2.14103936587178,-1.01373715849481,9.46568227274576e-21,1.74109393304317e-18,-1,dn,,Initial TCR Response,5,Phospholipase C complex,41,46,ITK,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,72,bortezomib,dmso,163,JUN,0.0322919287305923,0.364248438982397,0.0998437390657457,0.377010669259487,0.591450375804077,1,up,c-Jun,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,21,24,JUN | c-Jun,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,72,bortezomib,dmso,163,LAT,-0.0278139342843678,-1.89813085662772,-0.329063159748376,4.46675146456067e-08,1.27970118391633e-06,-1,dn,,Initial TCR Response,5,Phospholipase C complex,43,48,LAT,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,72,bortezomib,dmso,163,LCK,-0.0838561781073379,-1.76677527972941,-0.467853419504673,1.08092009480305e-09,4.14932326826787e-08,-1,dn,,Initial TCR Response,5,ITAM-targeting Kinase,52,57,LCK,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,72,bortezomib,dmso,163,LCP2,-0.298974929141888,-2.1976562217601,-0.997367583033502,8.21426743882767e-22,1.68659923761417e-19,-1,dn,SLP-76,Initial TCR Response,5,Phospholipase C complex,44,49,LCP2 | SLP-76,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,72,bortezomib,dmso,163,MALT1,0.0784538433704167,-0.647962326471625,-0.228125021497608,0.0087134947966088,0.0467952831868973,-1,dn,,PKCθ–IKK–NF-κβ pathway,4,CBM complex,33,37,MALT1,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,72,bortezomib,dmso,163,MAP2K1,0.247084818446554,0.278934915958962,0.2026543788305,0.00128303010542729,0.0102700569363713,1,up,MEK1,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,15,17,MAP2K1 | MEK1,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,72,bortezomib,dmso,163,MAP2K2,0.100797609594758,0.155529174926618,0.0564367768880107,0.287450994858428,0.506439981049544,1,up,MEK2,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,14,16,MAP2K2 | MEK2,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,72,bortezomib,dmso,163,MAP2K7,0.130811048501885,-0.609356434692197,-0.0569650989993757,0.137671448523226,0.323357600162692,-1,dn,MKK7,p38 and JNK pathways,1,JNK activation complex,9,10,MAP2K7 | MKK7,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,72,bortezomib,dmso,163,MAP3K7,0.120183859054064,0.205851492479706,0.121197488370022,0.114514316957743,0.288705569508826,1,up,TAK1,p38 and JNK pathways,1,JNK activation complex,10,11,MAP3K7 | TAK1,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,72,bortezomib,dmso,163,MAPK1,0.023588530011399,-0.0322035302257155,-0.00208131740755868,0.921976269124422,0.957775283110387,-1,dn,ERK2,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,13,15,MAPK1 | ERK2,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,72,bortezomib,dmso,163,MAPK14,0.0654547443634628,-0.0210836481403594,0.0181408354711754,0.591674683949067,0.756993324869497,1,up,p38ɑ,p38 and JNK pathways,1,p38,11,12,MAPK14 | p38ɑ,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,72,bortezomib,dmso,163,MAPK8,0.239769393517221,0.978079132139483,0.50434657143727,3.22782271636952e-06,6.15517208700355e-05,1,up,JNK1,p38 and JNK pathways,1,JNK activation complex,7,8,MAPK8 | JNK1,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,72,bortezomib,dmso,163,MAPK9,-0.0212723180462489,-0.143465262227519,-0.0310200194955697,0.870760015261071,0.928544386264707,-1,dn,JNK2,p38 and JNK pathways,1,JNK activation complex,8,9,MAPK9 | JNK2,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,72,bortezomib,dmso,163,MAPKAP1,0.0702479083630273,0.369396585415128,0.185346649068921,0.164566096100096,0.361547587750009,1,up,,mTORC pathways,0,mTORC2 complex,3,3,MAPKAP1,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,72,bortezomib,dmso,163,MTOR,0.0758895623980551,0.0848639335134685,0.0439641233679961,0.564306030781298,0.737414742572384,1,up,,mTORC pathways,0,mTORC1 complex,5,5,MTOR,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,72,bortezomib,dmso,163,NFATC1,0.00629640425473383,-0.0311668662922014,-0.00375972485187595,0.994076530145171,0.996791631815044,-1,dn,,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,25,28,NFATC1,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,72,bortezomib,dmso,163,NFKB1,-0.133202604787763,-0.550214502503429,-0.31004485147746,0.016159686234997,0.0739242848542946,-1,dn,NF-κB,PKCθ–IKK–NF-κβ pathway,4,NFKB complex,28,32,NFKB1 | NF-κB,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,72,bortezomib,dmso,163,NFKBIA,-0.0016125272346602,-0.21465695668764,-0.0649134282856042,0.685065127583255,0.819047634323057,-1,dn,IκBɑ,PKCθ–IKK–NF-κβ pathway,4,NFKB complex,26,30,NFKBIA | IκBɑ,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,72,bortezomib,dmso,163,PAG1,-0.287961363804455,-1.02378456971699,-0.62224752186493,1.24963971321942e-07,3.24502030235713e-06,-1,dn,,Initial TCR Response,5,TCR Regulator,46,51,PAG1,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,72,bortezomib,dmso,163,PDPK1,0.0822187738333675,-0.157256800002869,-0.0138532292982291,0.570638461667552,0.741615412146628,-1,dn,PDK1,PKCθ–IKK–NF-κβ pathway,4,CBM complex activator,35,39,PDPK1 | PDK1,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,72,bortezomib,dmso,163,PLCG1,-0.00735875211086234,-0.634679860819114,-0.10674118912289,0.125041645852322,0.304886510740868,-1,dn,PLC-γ1,Initial TCR Response,5,Phospholipase C complex,39,44,PLCG1 | PLC-γ1,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,72,bortezomib,dmso,163,PLCG2,-0.152019443831197,-1.25846210158532,-0.489404707613647,2.75601231235223e-07,6.68484414993346e-06,-1,dn,PLC-γ2,Initial TCR Response,5,Phospholipase C complex,38,43,PLCG2 | PLC-γ2,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,72,bortezomib,dmso,163,PPP3CA,-0.188561317788192,-1.25963167941443,-0.653254421944985,1.02794431897057e-07,2.70110725958069e-06,-1,dn,,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,24,27,PPP3CA,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,72,bortezomib,dmso,163,PPP3CB,-0.0962177597122388,-0.881129072550064,-0.288700136919922,0.000939235404491561,0.00794301665350191,-1,dn,,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,23,26,PPP3CB,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,72,bortezomib,dmso,163,PPP3CC,0.135964402157737,-0.200117722343649,0.00910121535309139,0.0629787838626614,0.193742049729421,1,up,,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,22,25,PPP3CC,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,72,bortezomib,dmso,163,PRKCQ,-0.279218338412438,-0.909736195973246,-0.552790143619958,2.68691960320836e-07,6.55326330848802e-06,-1,dn,PKC-Θ,PKCθ–IKK–NF-κβ pathway,4,CBM complex activator,37,41,PRKCQ | PKC-Θ,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,72,bortezomib,dmso,163,PRR5,0.0635684846849992,-0.636649965952359,-0.0527040941297783,0.259587769030934,0.479276539685093,-1,dn,,mTORC pathways,0,mTORC2 complex,2,2,PRR5,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,72,bortezomib,dmso,163,PTPN22,-0.113340205339668,-1.68570441318739,-0.408094839608387,2.56006451733844e-08,7.68803048421124e-07,-1,dn,Lyp/Pep,Initial TCR Response,5,TCR Negative Regulator,47,52,PTPN22 | Lyp/Pep,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,72,bortezomib,dmso,163,PTPRC,-0.863273040148691,-2.79498739189254,-1.2,5.47510146634982e-36,3.02122942790016e-33,-1,dn,CD45,Initial TCR Response,5,TCR Activator,49,54,PTPRC | CD45,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,72,bortezomib,dmso,163,PTPRJ,-0.0774432542353497,-0.669380852934625,-0.275156199794457,0.0137730429964815,0.0659447920910711,-1,dn,CD148,Initial TCR Response,5,TCR Activator,50,55,PTPRJ | CD148,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,72,bortezomib,dmso,163,RAF1,-0.0469909683121433,0.499664084232184,0.165777915890478,0.0861135992806738,0.239539057356354,1,up,c-RAF,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,16,18,RAF1 | c-RAF,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,72,bortezomib,dmso,163,RASGRP1,-0.184940680313774,-1.05818882028577,-0.533740892482947,5.0832611645809e-07,1.18105560058118e-05,-1,dn,,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,18,20,RASGRP1,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,72,bortezomib,dmso,163,RELA,0.139946905277049,0.654160853129793,0.0471694836932773,0.305093157501166,0.523855987471372,1,up,p65,PKCθ–IKK–NF-κβ pathway,4,NFKB complex,27,31,RELA | p65,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,72,bortezomib,dmso,163,RICTOR,0.160969798342601,0.252804239173271,0.21061326749256,0.034059897406578,0.126127180362908,1,up,,mTORC pathways,0,mTORC2 complex,1,1,RICTOR,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,72,bortezomib,dmso,163,RPTOR,0.280057673706445,1.47830596876091,0.666162707297472,1.74564229041392e-12,9.87966396286188e-11,1,up,,mTORC pathways,0,mTORC1 complex,4,4,RPTOR,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,72,bortezomib,dmso,163,SOS1,-0.576525540990516,-1.08245701465704,-0.713311922037061,2.04411665295485e-13,1.37726124169323e-11,-1,dn,,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,17,19,SOS1,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,72,bortezomib,dmso,163,TRAC,-0.138196854772624,-1.53888021665318,-0.597164288219483,4.91445062325414e-10,2.01812486291678e-08,-1,dn,TCRɑ,Initial TCR Response,5,TCR complex,58,63,TRAC | TCRɑ,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,72,bortezomib,dmso,163,TRAF6,0.0508024393004092,0.0453605396496134,0.0170132170154706,0.794156131992771,0.887165627783732,1,up,,PKCθ–IKK–NF-κβ pathway,4,CBM complex,32,36,TRAF6,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,72,bortezomib,dmso,163,TRBC1,-0.387847169269161,-0.95595492997634,-0.290580129995439,0.00016687897984336,0.0018889416833808,-1,dn,TCRβ,Initial TCR Response,5,TCR complex,59,64,TRBC1 | TCRβ,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,72,bortezomib,dmso,163,TXK,-0.10269277885889,-0.679554007017039,-0.273414930021453,0.0118453022740155,0.0587870566482758,-1,dn,,Initial TCR Response,5,Phospholipase C complex,40,45,TXK,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_memory,72,bortezomib,dmso,163,ZAP70,0.0292302275752684,-0.5718710366973,-0.0936212814965515,0.163502639772093,0.360060404140295,-1,dn,,Initial TCR Response,5,TCR Output,45,50,ZAP70,Bor/DMSO,CD8 Memory,#009444,6,2
t_cd8_naive,72,bortezomib,dmso,451,AKT1S1,0.0577656711597375,1.71846552075915,0.065551810209129,0.000126188880899655,0.000500221129105294,1,up,,mTORC pathways,0,mTORC1 complex,6,6,AKT1S1,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,72,bortezomib,dmso,451,BCL10,-0.016218865626321,0.419964425031919,0.0353833046986897,0.259254732539094,0.333838905416177,1,up,,PKCθ–IKK–NF-κβ pathway,4,CBM complex,36,40,BCL10,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,72,bortezomib,dmso,451,CARD11,0.0261797117681129,-0.0130723339653485,0.0103269391646319,0.84384733936767,0.864685436329853,1,up,CARMA1,PKCθ–IKK–NF-κβ pathway,4,CBM complex,34,38,CARD11 | CARMA1,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,72,bortezomib,dmso,451,CD247,0.069136695623373,-0.319091989497054,-0.0231066293362079,0.0574464557356248,0.10053407594979,-1,dn,CD3ζ,Initial TCR Response,5,TCR complex,56,61,CD247 | CD3ζ,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,72,bortezomib,dmso,451,CD3D,-0.091458214619827,-0.552139027935991,-0.254786405526591,5.2200063202926e-05,0.000225287104834765,-1,dn,CD3δ,Initial TCR Response,5,TCR complex,60,65,CD3D | CD3δ,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,72,bortezomib,dmso,451,CD3E,-0.132472252276579,-2.33192086145916,-0.615231597594441,2.61084237045542e-42,1.69911367504602e-40,-1,dn,CD3ε,Initial TCR Response,5,TCR complex,61,66,CD3E | CD3ε,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,72,bortezomib,dmso,451,CD3G,-0.0908334231219235,-2.12995026010132,-0.596375944936601,2.81363579166399e-36,1.36839512749422e-34,-1,dn,CD3γ,Initial TCR Response,5,TCR complex,57,62,CD3G | CD3γ,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,72,bortezomib,dmso,451,CD8A,-0.275063048227145,-2.45177122722163,-0.825998652073558,6.43389871161264e-56,6.5394435668818e-54,-1,dn,CD8ɑ,Initial TCR Response,5,TCR Coreceptor,54,59,CD8A | CD8ɑ,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,72,bortezomib,dmso,451,CD8B,-0.305375303577758,-1.85819135483288,-0.847902086715659,1.69987370611314e-43,1.16492860193178e-41,-1,dn,CD8β,Initial TCR Response,5,TCR Coreceptor,53,58,CD8B | CD8β,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,72,bortezomib,dmso,451,CHUK,0.046133968561215,0.335276831566769,0.0602310775490642,0.157801242256428,0.224727650732312,1,up,IKKɑ,PKCθ–IKK–NF-κβ pathway,4,IKb Kinase complex,30,34,CHUK | IKKɑ,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,72,bortezomib,dmso,451,CSK,-0.00158532661743743,-0.332789929330639,-0.0586489466096254,0.206951154457979,0.27941494675028,-1,dn,,Initial TCR Response,5,TCR Negative Regulator,48,53,CSK,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,72,bortezomib,dmso,451,DGKA,0.000624086218309975,-0.979723405921414,-0.302782217598186,5.88414338396609e-10,5.41484853014825e-09,-1,dn,DGKɑ,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,19,22,DGKA | DGKɑ,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,72,bortezomib,dmso,451,FYN,0.205006705677305,0.443888935686517,0.297988513448261,1.31316343615982e-07,8.81222288093598e-07,1,up,,Initial TCR Response,5,ITAM-targeting Kinase,51,56,FYN,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,72,bortezomib,dmso,451,GRAP2,-0.249696144727643,-2.54202489560472,-1.07079565631306,1.28749465764582e-62,1.66381095329487e-60,-1,dn,GADS,Initial TCR Response,5,Phospholipase C complex,42,47,GRAP2 | GADS,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,72,bortezomib,dmso,451,IKBKB,0.00203199172669376,-0.509300647039064,-0.125077017252728,0.00747897924068469,0.0184748351204898,-1,dn,IKKβ,PKCθ–IKK–NF-κβ pathway,4,IKb Kinase complex,31,35,IKBKB | IKKβ,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,72,bortezomib,dmso,451,IKBKG,0.0568898931436121,0.574161095871851,0.0404512089194057,0.0614931799464737,0.106372281641491,1,up,IKKγ,PKCθ–IKK–NF-κβ pathway,4,IKb Kinase complex,29,33,IKBKG | IKKγ,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,72,bortezomib,dmso,451,ITK,-0.474070845586694,-2.94893342635701,-1.2,1.9727068821851e-86,4.82300174493146e-84,-1,dn,,Initial TCR Response,5,Phospholipase C complex,41,46,ITK,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,72,bortezomib,dmso,451,JUN,0.117231714051587,1.30658436127002,0.262307556844865,1.0073457424897e-11,1.10857050931409e-10,1,up,c-Jun,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,21,24,JUN | c-Jun,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,72,bortezomib,dmso,451,LAT,-0.0915729622020599,-2.16494722175809,-0.342722635170672,5.19672432466037e-23,1.31311643130943e-21,-1,dn,,Initial TCR Response,5,Phospholipase C complex,43,48,LAT,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,72,bortezomib,dmso,451,LCK,-0.11696452160421,-1.62258284408839,-0.507915902059948,2.71942143689032e-24,7.42255601786908e-23,-1,dn,,Initial TCR Response,5,ITAM-targeting Kinase,52,57,LCK,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,72,bortezomib,dmso,451,LCP2,-0.151591746835509,-1.25977367777006,-0.503357622308133,2.11823572395045e-19,4.30596861996759e-18,-1,dn,SLP-76,Initial TCR Response,5,Phospholipase C complex,44,49,LCP2 | SLP-76,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,72,bortezomib,dmso,451,MALT1,-0.0186475935704336,-0.611563475935099,-0.249500346295634,9.75985769004745e-05,0.000398050823553513,-1,dn,,PKCθ–IKK–NF-κβ pathway,4,CBM complex,33,37,MALT1,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,72,bortezomib,dmso,451,MAP2K1,0.0768058213202655,0.594072540932089,0.246861248072426,4.58188893196462e-05,0.000200812825961977,1,up,MEK1,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,15,17,MAP2K1 | MEK1,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,72,bortezomib,dmso,451,MAP2K2,0.10528557514741,0.389387995888492,0.0774641295719198,0.00389258052504528,0.0105647415030182,1,up,MEK2,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,14,16,MAP2K2 | MEK2,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,72,bortezomib,dmso,451,MAP2K7,0.000515707562472023,-0.260869142520838,-0.0256561348577668,0.558936713484429,0.620613908209174,-1,dn,MKK7,p38 and JNK pathways,1,JNK activation complex,9,10,MAP2K7 | MKK7,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,72,bortezomib,dmso,451,MAP3K7,0.139554893709406,0.518452498942185,0.244683333252701,2.76252556484523e-06,1.5331169484411e-05,1,up,TAK1,p38 and JNK pathways,1,JNK activation complex,10,11,MAP3K7 | TAK1,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,72,bortezomib,dmso,451,MAPK1,0.0806980563661989,0.197018947359797,0.100115946311561,0.0438264870786041,0.0807278359016602,1,up,ERK2,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,13,15,MAPK1 | ERK2,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,72,bortezomib,dmso,451,MAPK14,0.0204743818256559,0.0803489389695577,0.0385454318606883,0.748405038719741,0.784936241349668,1,up,p38ɑ,p38 and JNK pathways,1,p38,11,12,MAPK14 | p38ɑ,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,72,bortezomib,dmso,451,MAPK8,0.237497489996217,1.17895399483669,0.623661496456942,4.24547919246793e-20,8.99405264053042e-19,1,up,JNK1,p38 and JNK pathways,1,JNK activation complex,7,8,MAPK8 | JNK1,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,72,bortezomib,dmso,451,MAPK9,0.0834747062927158,0.736883166798265,0.141199794864351,0.000363842719318584,0.00128818835184184,1,up,JNK2,p38 and JNK pathways,1,JNK activation complex,8,9,MAPK9 | JNK2,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,72,bortezomib,dmso,451,MAPKAP1,0.112922187213086,0.161274590858518,0.120599218465628,0.0178736678457102,0.0387561141910902,1,up,,mTORC pathways,0,mTORC2 complex,3,3,MAPKAP1,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,72,bortezomib,dmso,451,MTOR,0.119302239106499,0.239267183308263,0.0922450431956154,0.00269634517040834,0.00766761305503142,1,up,,mTORC pathways,0,mTORC1 complex,5,5,MTOR,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,72,bortezomib,dmso,451,NFATC1,0.00246663248064394,0.0168409051680729,0.00235006750976569,0.996851599624698,0.997106592258877,1,up,,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,25,28,NFATC1,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,72,bortezomib,dmso,451,NFKB1,-0.179943168867391,-0.792748680518646,-0.403621917243599,2.42258848529427e-10,2.32887730477917e-09,-1,dn,NF-κB,PKCθ–IKK–NF-κβ pathway,4,NFKB complex,28,32,NFKB1 | NF-κB,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,72,bortezomib,dmso,451,NFKBIA,0.0650069374227572,0.175074218771224,0.0450563622390057,0.128035731988131,0.190620676689374,1,up,IκBɑ,PKCθ–IKK–NF-κβ pathway,4,NFKB complex,26,30,NFKBIA | IκBɑ,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,72,bortezomib,dmso,451,PAG1,-0.110635284679991,-0.958824897108425,-0.425355384754443,1.23962428267289e-10,1.22286164242737e-09,-1,dn,,Initial TCR Response,5,TCR Regulator,46,51,PAG1,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,72,bortezomib,dmso,451,PDPK1,0.0727967971427463,0.36501349199138,0.0672819034132564,0.0173933563560846,0.0379027169319437,1,up,PDK1,PKCθ–IKK–NF-κβ pathway,4,CBM complex activator,35,39,PDPK1 | PDK1,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,72,bortezomib,dmso,451,PLCG1,0.0599053041754303,-0.896174252732509,-0.153982163021183,2.13735066294204e-06,1.21371463257839e-05,-1,dn,PLC-γ1,Initial TCR Response,5,Phospholipase C complex,39,44,PLCG1 | PLC-γ1,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,72,bortezomib,dmso,451,PLCG2,-0.403154685559953,-1.18309661682343,-0.549849020107849,1.5947359343159e-26,4.94040454171972e-25,-1,dn,PLC-γ2,Initial TCR Response,5,Phospholipase C complex,38,43,PLCG2 | PLC-γ2,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,72,bortezomib,dmso,451,PPP3CA,-0.0174743075191045,-0.692742067951399,-0.308431603144445,1.14158026719475e-05,5.70369217601669e-05,-1,dn,,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,24,27,PPP3CA,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,72,bortezomib,dmso,451,PPP3CB,-0.0170063012856458,-0.393131271671162,-0.124410748486432,0.0343719737147578,0.0662114297750637,-1,dn,,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,23,26,PPP3CB,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,72,bortezomib,dmso,451,PPP3CC,0.0936435042621273,-0.0160891833700966,0.0444252621637956,0.0768400714500887,0.1269812360865,1,up,,Ca2+–calcineurin–NFAT pathway,3,Ca-calcineurin-NFAT,22,25,PPP3CC,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,72,bortezomib,dmso,451,PRKCQ,-0.101586117019637,-0.848781876011969,-0.391018356656362,3.62864566282923e-09,3.04496555342794e-08,-1,dn,PKC-Θ,PKCθ–IKK–NF-κβ pathway,4,CBM complex activator,37,41,PRKCQ | PKC-Θ,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,72,bortezomib,dmso,451,PRR5,0.0104611991434152,-0.49212107164248,-0.0398979503077279,0.173788606765167,0.242270263029388,-1,dn,,mTORC pathways,0,mTORC2 complex,2,2,PRR5,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,72,bortezomib,dmso,451,PTPN22,-0.0790046576874476,-2.09554982910402,-0.378233427853828,3.43177708740932e-23,8.794293352041e-22,-1,dn,Lyp/Pep,Initial TCR Response,5,TCR Negative Regulator,47,52,PTPN22 | Lyp/Pep,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,72,bortezomib,dmso,451,PTPRC,-0.687983524062583,-2.72092192496706,-1.00497382582122,2.37626444046267e-71,3.8385157372188e-69,-1,dn,CD45,Initial TCR Response,5,TCR Activator,49,54,PTPRC | CD45,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,72,bortezomib,dmso,451,PTPRJ,0.0401672644073889,-0.732185924633408,-0.173513920559042,6.60395737267675e-05,0.000278895417335359,-1,dn,CD148,Initial TCR Response,5,TCR Activator,50,55,PTPRJ | CD148,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,72,bortezomib,dmso,451,RAF1,0.103336066038865,0.154030962625969,0.0990409243952617,0.0158522094025895,0.0349753868916644,1,up,c-RAF,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,16,18,RAF1 | c-RAF,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,72,bortezomib,dmso,451,RASGRP1,0.0147127466598091,-0.240655962040087,-0.0841442787785172,0.22725237326034,0.300806694589641,-1,dn,,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,18,20,RASGRP1,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,72,bortezomib,dmso,451,RELA,0.0995587498445028,1.11502759940113,0.0874175558185408,8.42297278298198e-05,0.000347284465792411,1,up,p65,PKCθ–IKK–NF-κβ pathway,4,NFKB complex,27,31,RELA | p65,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,72,bortezomib,dmso,451,RICTOR,0.192756286278916,0.335392113574059,0.252253872245043,1.51955099813205e-06,8.79453507940019e-06,1,up,,mTORC pathways,0,mTORC2 complex,1,1,RICTOR,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,72,bortezomib,dmso,451,RPTOR,0.220353051803841,1.24383823958696,0.571206430335665,3.31913419140939e-23,8.55409911552404e-22,1,up,,mTORC pathways,0,mTORC1 complex,4,4,RPTOR,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,72,bortezomib,dmso,451,SOS1,-0.720641836349488,-2.15119464024756,-0.970822619185844,7.77417027903255e-68,1.17208573906881e-65,-1,dn,,RASGRP1–RAS–ERK1/2–AP1 pathway,2,RASGRP1-RAS-ERK1/2-AP1,17,19,SOS1,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,72,bortezomib,dmso,451,TRAC,-0.254525418624951,-1.67297490825705,-0.690848420289536,1.01580947212114e-34,4.71231409477323e-33,-1,dn,TCRɑ,Initial TCR Response,5,TCR complex,58,63,TRAC | TCRɑ,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,72,bortezomib,dmso,451,TRAF6,0.0978986854010415,0.879668964833276,0.175064223888729,2.22701675059813e-06,1.25831314965088e-05,1,up,,PKCθ–IKK–NF-κβ pathway,4,CBM complex,32,36,TRAF6,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,72,bortezomib,dmso,451,TRBC1,-0.276403117577573,-1.02235028540426,-0.306758783478122,1.26323587204242e-11,1.37677490343322e-10,-1,dn,TCRβ,Initial TCR Response,5,TCR complex,59,64,TRBC1 | TCRβ,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,72,bortezomib,dmso,451,TXK,-0.313412493122943,-2.55904180932374,-1.17131921158322,6.2263474161362e-63,8.16283169947364e-61,-1,dn,,Initial TCR Response,5,Phospholipase C complex,40,45,TXK,Bor/DMSO,CD8 Naive,#8DC63F,5,3
t_cd8_naive,72,bortezomib,dmso,451,ZAP70,0.0343038624473682,-0.743702310130133,-0.154276241585882,4.65558330987935e-05,0.000203549572842768,-1,dn,,Initial TCR Response,5,TCR Output,45,50,ZAP70,Bor/DMSO,CD8 Naive,#8DC63F,5,3
